Zhem的个人主页 - 老虎社区

Zhem

Zhem

暂无个人介绍

IP属地：未知

138关注

41粉丝

1主题

0勋章

2021-06-18

Nicee

Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy

2021-11-01

Ho

抱歉，原内容已删除

2021-08-02

Niceeeee

Tesla rose nearly 5% in morning trading

2021-10-29

Ho

Charts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips

2021-09-23

Niceee

抱歉，原内容已删除

2021-09-17

Ho

After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more

2021-06-26

Awesome

抱歉，原内容已删除

2021-06-19

Thanksss!

抱歉，原内容已删除

2021-06-21

Coool

Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week

2021-11-06

Ho

Buffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results

2021-11-04

Ho

S&P 500 rises for a sixth straight day, Dow hovers near a record

2021-10-28

Ho

抱歉，原内容已删除

2021-10-20

Ho

Toplines Before US Market Open on Wednesday

2021-10-07

Ho

Charlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?

2021-09-30

Ho

Cathie Wood’s ARK Invest Sold Tesla Stock. Bulls Shouldn’t Worry.

2021-07-01

Interesting

Amazon: Undervalued With Potential Upside Of 25%

2021-06-25

Wowww

抱歉，原内容已删除

2021-06-22

Thankss

These 3 Dow Stocks Are Set to Soar in 2021's Second Half

2021-11-08

Ho

抱歉，原内容已删除

2021-09-28

Hohoho

Sonoma Pharmaceuticals shares surged 45% in premarket trading

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575931986549530","uuid":"3575931986549530","gmtCreate":1612837962869,"gmtModify":1623940837569,"name":"Zhem","pinyin":"zhem","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":41,"headSize":138,"tweetSize":58,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.24","exceedPercentage":"80.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":844027106,"gmtCreate":1636379246232,"gmtModify":1636379278835,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844027106","repostId":"1114414245","repostType":4,"isVote":1,"tweetType":1,"viewCount":1225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842570716,"gmtCreate":1636208791035,"gmtModify":1636208791623,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842570716","repostId":"2181374735","repostType":4,"repost":{"id":"2181374735","kind":"news","pubTimestamp":1636200960,"share":"https://ttm.financial/m/news/2181374735?lang=&edition=full","pubTime":"2021-11-06 20:16","market":"us","language":"en","title":"Buffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results","url":"https://stock-news.laohu8.com/highlight/detail?id=2181374735","media":"StreetInsider","summary":"(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound fro","content":"<p>(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater loss from insurance underwriting.</p>\n<p>Berkshire also said it repurchased $7.6 billion of its own stock in the third quarter, reflecting its need to put some cash to work as stock prices regularly set new highs and purchases of whole companies appear too expensive.</p>\n<p>Quarterly operating profit rose 18% to $6.47 billion compared with $5.48 billion in the year-earlier period.</p>\n<p>Net income declined 66% to $10.3 billion, or $6,882 per Class A share, from $30.1 billion, reflecting lower unrealized gains on Berkshire's common stock holdings including Apple Inc and $Bank of America Corp(BAC-N)$.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19172264><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19172264\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19172264","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181374735","content_text":"(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater loss from insurance underwriting.\nBerkshire also said it repurchased $7.6 billion of its own stock in the third quarter, reflecting its need to put some cash to work as stock prices regularly set new highs and purchases of whole companies appear too expensive.\nQuarterly operating profit rose 18% to $6.47 billion compared with $5.48 billion in the year-earlier period.\nNet income declined 66% to $10.3 billion, or $6,882 per Class A share, from $30.1 billion, reflecting lower unrealized gains on Berkshire's common stock holdings including Apple Inc and $Bank of America Corp(BAC-N)$.","news_type":1,"symbols_score_info":{"BRK.A":0.9,"BRK.B":0.9}},"isVote":1,"tweetType":1,"viewCount":1287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846097695,"gmtCreate":1636034157304,"gmtModify":1636034157902,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846097695","repostId":"1103660582","repostType":4,"isVote":1,"tweetType":1,"viewCount":1736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841706088,"gmtCreate":1635940146017,"gmtModify":1635940146748,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841706088","repostId":"2180782003","repostType":4,"repost":{"id":"2180782003","kind":"highlight","pubTimestamp":1635910680,"share":"https://ttm.financial/m/news/2180782003?lang=&edition=full","pubTime":"2021-11-03 11:38","market":"us","language":"en","title":"1 Red-Hot Semiconductor Stock That Just Crushed Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2180782003","media":"Motley Fool","summary":"Despite overwhelming strength in semiconductor stocks this year, Cohu still presents great value.","content":"<p>Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't get their hands on enough computer chips.</p>\n<p>New cars are <a href=\"https://laohu8.com/S/AONE.U\">one</a> enormous source of demand for semiconductors, especially with the growth of electric vehicles, and dealer lots are currently running on a fraction of the inventory they need to meet demand.</p>\n<p>The issue has pushed consumers into the used car market, sending prices soaring 24.4% on average over the last 12 months. But semiconductor-service powerhouse <b>Cohu </b>(NASDAQ:COHU) is helping to alleviate these supply pressures, and it just delivered another big quarterly result. Here's how.</p>\n<h2>Automotive chips continue driving Cohu forward</h2>\n<p>Cohu provides testing and handling equipment to the world's largest semiconductor producers, assisting in the manufacture of computer chips for a range of applications including consumer electronics, mobility, and even the automotive market.</p>\n<p>That segment has grown to become the company's largest, accounting for 20% of total revenue in the third quarter just announced, up from 18% in the second quarter. It highlights persistent demand from semiconductor producers that need to expand manufacturing capacity in preparation for a future consisting of smarter, more feature-heavy vehicles.</p>\n<p>But it also displays Cohu's clever strategic focus, pivoting its attention to where it's needed most right now, which is helping producers clear order backlogs and relieve shortages.</p>\n<p>Its Neon inspection and high-speed handling systems are designed to rapidly inspect computer chips as small as 0.2 millimeters by 0.4 millimeters, which are often used in automotive applications. These fragile components require delicate yet fast handling, so defects can be detected in efficient time frames so as not to hold up the production process.</p>\n<p>Cohu's portfolio of automotive-related semiconductor equipment also extends to real-world-style environmental testing to ensure chips can withstand the stresses of everyday use. It also offers the capability to test and handle chips for new technologies like autonomous driving and broad electrification, which should play a significant role in the future of the automotive industry.</p>\n<h2>Strong third-quarter results</h2>\n<p>Cohu delivered 49% year-over-year revenue growth and 159% year-over-year earnings per share growth in the third quarter. Its $0.70 in third-quarter EPS adds to what is expected to be the company's first profitable year since 2017, after spending several years investing in the business.</p>\n<p>Overall, as the end of the year approaches, 2021 financial results are set to crush what Cohu delivered in 2020.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>2020</p></th>\n   <th><p>2021 (Estimate)</p></th>\n   <th><p>Growth</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td><p>Revenue</p></td>\n   <td><p>$636 million</p></td>\n   <td><p>$902 million</p></td>\n   <td><p>41%</p></td>\n  </tr>\n  <tr>\n   <td><p>EPS (Loss)</p></td>\n   <td><p>($0.33)</p></td>\n   <td><p>$3.05</p></td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Cohu, Yahoo! Finance.</p>\n<p>The company's 41% estimated revenue growth would more than quadruple the 9% it generated in 2020 (when compared to 2019).</p>\n<p>Cohu is so comfortable with its financial position right now that it just announced a $70 million share buyback program to return money to shareholders. It's not something investors would typically see from a relatively small $1.5 billion growth company, but it's an added benefit to the 47% rise in share price over the last 12 months.</p>\n<h2>Why you should buy the stock</h2>\n<p>When it comes to semiconductor stocks, many of them have experienced red-hot share price growth lately as investors price in higher profits from rising demand and low supply. Regardless, Cohu remains incredibly cheap compared to its peers.</p>\n<p>The <b><a href=\"https://laohu8.com/S/EEME\">iShares</a> Semiconductor ETF </b>trades at a price-to-earnings multiple of 33, compared to a multiple of less than 11 for Cohu based on $3.05 in 2021 EPS. That means the stock would need to triple to align with the broader industry on a valuation basis.</p>\n<p>Analysts expect Cohu to be just as profitable in 2022, so investors shouldn't be concerned that 2021 was a one-off result following a few years of losses. It aligns with the broader sentiment among car manufacturers, which suggests semiconductor shortages will persist well into the new year. That will only mean one thing: Demand for Cohu's testing and handling equipment is likely to remain elevated.</p>\n<p>Cohu's strong third quarter is just another piece in its overwhelmingly positive story. Wall Street is certainly on board, with one firm predicting the stock will more than double from here.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Red-Hot Semiconductor Stock That Just Crushed Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Red-Hot Semiconductor Stock That Just Crushed Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-03 11:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COHU":"科休半导体"},"source_url":"https://www.fool.com/investing/2021/11/02/1-semiconductor-stock-that-just-crushed-earnings/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180782003","content_text":"Semiconductor shortages have dominated headlines in the business world this year. Manufacturers of consumer goods across the globe are struggling to meet their production targets because they can't get their hands on enough computer chips.\nNew cars are one enormous source of demand for semiconductors, especially with the growth of electric vehicles, and dealer lots are currently running on a fraction of the inventory they need to meet demand.\nThe issue has pushed consumers into the used car market, sending prices soaring 24.4% on average over the last 12 months. But semiconductor-service powerhouse Cohu (NASDAQ:COHU) is helping to alleviate these supply pressures, and it just delivered another big quarterly result. Here's how.\nAutomotive chips continue driving Cohu forward\nCohu provides testing and handling equipment to the world's largest semiconductor producers, assisting in the manufacture of computer chips for a range of applications including consumer electronics, mobility, and even the automotive market.\nThat segment has grown to become the company's largest, accounting for 20% of total revenue in the third quarter just announced, up from 18% in the second quarter. It highlights persistent demand from semiconductor producers that need to expand manufacturing capacity in preparation for a future consisting of smarter, more feature-heavy vehicles.\nBut it also displays Cohu's clever strategic focus, pivoting its attention to where it's needed most right now, which is helping producers clear order backlogs and relieve shortages.\nIts Neon inspection and high-speed handling systems are designed to rapidly inspect computer chips as small as 0.2 millimeters by 0.4 millimeters, which are often used in automotive applications. These fragile components require delicate yet fast handling, so defects can be detected in efficient time frames so as not to hold up the production process.\nCohu's portfolio of automotive-related semiconductor equipment also extends to real-world-style environmental testing to ensure chips can withstand the stresses of everyday use. It also offers the capability to test and handle chips for new technologies like autonomous driving and broad electrification, which should play a significant role in the future of the automotive industry.\nStrong third-quarter results\nCohu delivered 49% year-over-year revenue growth and 159% year-over-year earnings per share growth in the third quarter. Its $0.70 in third-quarter EPS adds to what is expected to be the company's first profitable year since 2017, after spending several years investing in the business.\nOverall, as the end of the year approaches, 2021 financial results are set to crush what Cohu delivered in 2020.\n\n\n\nMetric\n2020\n2021 (Estimate)\nGrowth\n\n\n\n\nRevenue\n$636 million\n$902 million\n41%\n\n\nEPS (Loss)\n($0.33)\n$3.05\nN/A\n\n\n\nData source: Cohu, Yahoo! Finance.\nThe company's 41% estimated revenue growth would more than quadruple the 9% it generated in 2020 (when compared to 2019).\nCohu is so comfortable with its financial position right now that it just announced a $70 million share buyback program to return money to shareholders. It's not something investors would typically see from a relatively small $1.5 billion growth company, but it's an added benefit to the 47% rise in share price over the last 12 months.\nWhy you should buy the stock\nWhen it comes to semiconductor stocks, many of them have experienced red-hot share price growth lately as investors price in higher profits from rising demand and low supply. Regardless, Cohu remains incredibly cheap compared to its peers.\nThe iShares Semiconductor ETF trades at a price-to-earnings multiple of 33, compared to a multiple of less than 11 for Cohu based on $3.05 in 2021 EPS. That means the stock would need to triple to align with the broader industry on a valuation basis.\nAnalysts expect Cohu to be just as profitable in 2022, so investors shouldn't be concerned that 2021 was a one-off result following a few years of losses. It aligns with the broader sentiment among car manufacturers, which suggests semiconductor shortages will persist well into the new year. That will only mean one thing: Demand for Cohu's testing and handling equipment is likely to remain elevated.\nCohu's strong third quarter is just another piece in its overwhelmingly positive story. Wall Street is certainly on board, with one firm predicting the stock will more than double from here.","news_type":1,"symbols_score_info":{"COHU":0.9}},"isVote":1,"tweetType":1,"viewCount":1748,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849544565,"gmtCreate":1635770093075,"gmtModify":1635770093291,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849544565","repostId":"1121087038","repostType":4,"isVote":1,"tweetType":1,"viewCount":1580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857691252,"gmtCreate":1635520627145,"gmtModify":1635520627300,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857691252","repostId":"1138275414","repostType":4,"repost":{"id":"1138275414","kind":"news","pubTimestamp":1635513832,"share":"https://ttm.financial/m/news/1138275414?lang=&edition=full","pubTime":"2021-10-29 21:23","market":"us","language":"en","title":"Charts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1138275414","media":"Bloomberg","summary":"Halloween -- a time when terrifying things pop out from around every corner but none do you harm. Th","content":"<p>Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.</p>\n<p>It hasn’t escaped Wall Street that 2021 has been mostly treats and no tricks, with the S&amp;P 500 up 22% so far. But investors see plenty of dangers ahead, including corporate debt levels, lofty valuations and inflation’s persistent grip.</p>\n<p>Here are the charts inducing nightmares on Wall Street:</p>\n<p>Lucas Kawa, asset allocation strategist at UBS Asset Management:</p>\n<p>“The scariest chart in finance is the divergence between the market’s short-term expectations around Federal Reserve policy and long-term real rates. The yield on the 5th Eurodollar contract -- a proxy to gauge how much the U.S. central bank might tighten policy by December 2022, in this instance -- has risen by over 30 basis points in the last month. Meanwhile, 10-year real yields have retreated to near record lows below -1.1%, down almost 30 basis points over the same span. This combination of Fed expectations rising at least 25 basis points with 10-year real yields falling a minimum of 25 basis points over a rolling one-month period is extremely rare, occurring only one other time, in February 2009.”</p>\n<p><img src=\"https://static.tigerbbs.com/edb31ff1f84a03fb8269077437d7da8f\" tg-width=\"1200\" tg-height=\"707\" width=\"100%\" height=\"auto\">“Here are a few possible options, some of which are spookier than others: One, expectations regarding Fed tightening are too hawkish, and may be reversed by some mix of underwhelming activity data, cooling inflation, or central bank communications. Two, the fixed income market doesn’t think the economy will remain resilient following these rate hikes, which may prove to be a policy mistake and cause a growth scare. That’s not an outcome the stock market appears to be ascribing too much probability to at the moment! And three, real yields may adjust upwards to acknowledge the strong runway for both growth and inflation this cycle. This would likely be positive for our preferred procyclical relative value equity positions. However, a disorderly rise in real yields could challenge equity valuations at the index level, and the growth-oriented, expensive segments of the market in particular.”</p>\n<p>Deepak Puri, chief investment officer at Americas at Deutsche Bank Wealth Management:</p>\n<p>“Bond markets appear to have finally reached a turning point after 40 years of yields being driven lower by a combination of falling inflation rates and accommodative central bank policy. Taking advantage of the loosening financial conditions, corporates have steadily increased the appetite for debt over time with a considerable increase during the Covid-19 pandemic in part supported by the Federal Reserve’s stopgap measures to protect markets. As we enter a new investment landscape where inflation is returning after a long absence and central banks are becoming hawkish almost in unison, what impact will a tighter rate cycle and higher yields have on corporate profitability and the all-round health of their balance sheets?”</p>\n<p><img src=\"https://static.tigerbbs.com/917c68634fca6219a21635daa969ec3d\" tg-width=\"1200\" tg-height=\"724\" width=\"100%\" height=\"auto\"></p>\n<p>Katie Koch, co-head of fundamental equity within Goldman Sachs Asset Management:</p>\n<p>“Lead times -- the time between when a semiconductor is ordered and when it is delivered -- rose to a record of nearly 22 weeks in October, almost double pre-pandemic lead times. The pandemic has exposed the fragility of global supply chains, which is best illustrated by the global chip famine that has paralyzed industries, companies, and governments. Given how critical chips are to the advancement of technologies globally, we expect chip manufacturers to prioritize supply-chain resilience over efficiency by reshoring semiconductor production. It is worth noting that delays in chip delivery times moderated in October, which may suggest the chip shortage has peaked but there is a long road ahead for normalization.”</p>\n<p><img src=\"https://static.tigerbbs.com/065a99b9847793a19c545d407054ed0e\" tg-width=\"1200\" tg-height=\"646\" width=\"100%\" height=\"auto\"></p>\n<p>Ben Emons, strategist at Medley Global Advisors:</p>\n<p>“The U.S. inflation market is subject to ‘hot money.’ The Fed’s holdings of TIPs (Treasury inflation-protected securities) and retail assets invested in the largest TIP ETF show how much anxiety there is about inflation. That is also where the risk is when inflation does moderate next year, and that could lead to a dislocation of real interest rates.”</p>\n<p><img src=\"https://static.tigerbbs.com/598faca2b2e6631bdabe998c8b809600\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\">Steve Sosnick, chief strategist at Interactive Brokers:</p>\n<p>“I’m calling this graph ‘What Happens to a Meme Deferred?’ It’s the combined market cap of 12 of the ‘OG’ meme stocks. I find it fascinating that even after they’ve faded from the market’s consciousness, they’ve been able to maintain a gain of nearly 300% year-to-date.”</p>\n<p>“If we add in HOOD and consider it a meme stock, the total market cap exceeds the old highs.” In comparison, he said, the combined market value of Dogecoin and Shiba Inu coins exceeds $50 billion.”</p>\n<p><img src=\"https://static.tigerbbs.com/b79e8394a6298f1dfd985fc23caad350\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Kara Murphy, Chief Investment Officer of Kestra Investment Management:</p>\n<p>“The volatility in Bitcoin and other cryptocurrencies is about as spooky as they come, positively dwarfing the volatility seen in more traditional asset classes. The recent upswing has attracted much attention from investors who are eager to participate in the upside, yet may be tempted to ignore the potential risks. Investors would do well to remember the tricks that come with these treats.”</p>\n<p><img src=\"https://static.tigerbbs.com/bc2efb02417527c7876c435593d328cb\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Steve Chiavarone, portfolio manager and head of multi-asset solutions at Federated Hermes:</p>\n<p>“The 2021 scariest chart is … federal tax revenue and spending as % of GDP. Tax revenue as a percentage of GDP is currently 19.4% -- which is just a touch below an all-time high. Regardless of marginal rates or tax structure, the U.S. has never been able to generate tax revenues in excess of 20% of GDP -- a concept known as Hauser’s Law. Once tax revenues reach the 20% of GDP level, they historically have either led to more tax avoidance and/or a slowdown in economic activity that ultimately pushes revenues lower. At the same time, government spending of 32.9% of GDP is the highest since WWII, with no real signs of abating given current negotiations over further large spending bills. Together these raise the ‘spooky’ possibility of further upward pressure on inflation via profligate spending alongside tax proposals that could, at the same time, disincentivize investment and hurt both shorter- and longer-term growth prospects.”</p>\n<p><img src=\"https://static.tigerbbs.com/c558130d717a3355ff3686f7fe891931\" tg-width=\"1200\" tg-height=\"699\" width=\"100%\" height=\"auto\"></p>\n<p>Liz Ann Sonders, Charles Schwab’s chief investment strategist:</p>\n<p>“Never before has the stock market been valued as much as it is today relative to the size of the total economy; which suggests the stock market has never been more important as an economic driver as it is today.”</p>\n<p><img src=\"https://static.tigerbbs.com/a1d0952b2176148687569c525c7b69d9\" tg-width=\"1200\" tg-height=\"500\" width=\"100%\" height=\"auto\"></p>\n<p>Marlena Lee, global head of investment solutions at Dimensional Fund Advisors:</p>\n<p>“This Halloween, beware of investment funds in ‘green’ costumes. Investors searching for portfolios reflecting concerns about climate change may find ESG labels more trick than treat. One in four funds branded as ‘sustainability focused’ show less than 7% reduction in exposure to greenhouse gas (GHG) emissions intensity in comparison to the exposure of the broad market Russell 3000 index. This may be spooky for investors assuming ESG labeling to be a reliable indicator of less exposure to GHG-emitting companies.”<img src=\"https://static.tigerbbs.com/de0395a9c798571b5311ec7f38bd591f\" tg-width=\"1200\" tg-height=\"764\" width=\"100%\" height=\"auto\"></p>\n<p>Ross Mayfield, investment strategy analyst at Baird:</p>\n<p>“Amid the Covid-19 outbreak and subsequent stock market crash, investors piled into money market funds. However, 18 months and one historic rally later, cash on the sidelines remains elevated. Not only is cash earning next to nothing at a time when inflationary pressure is weighing on real returns, but getting back into an equity market near all-time highs is psychologically challenging (particularly one that has presented just a single -5% dip in the last year). It’s scary to think about the double-sided impact this could have on savers and investors long-term.”</p>\n<p><img src=\"https://static.tigerbbs.com/94e4838b203c2c5affd2631839be1cf8\" tg-width=\"1200\" tg-height=\"881\" width=\"100%\" height=\"auto\"></p>\n<p>Wes Crill, head of investment strategists at Dimensional Fund Advisors:</p>\n<p>“Investors expecting momentum strategies to diversify their value exposure may be spooked by the potential overlap between these two. Combining momentum and value strategies may inadvertently double down on one’s value tilt, a scary proposition for those wanting consistent exposure to value. Stocks with high profitability have had a more consistently low overlap with value, the two complementing each other like candy and corn.”</p>\n<p><img src=\"https://static.tigerbbs.com/6d29c10c022e7d500a26d11644780f89\" tg-width=\"1200\" tg-height=\"813\" width=\"100%\" height=\"auto\"></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-29 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.\nIt hasn’t escaped Wall Street that 2021...</p>\n\n<a href=\"https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138275414","content_text":"Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.\nIt hasn’t escaped Wall Street that 2021 has been mostly treats and no tricks, with the S&P 500 up 22% so far. But investors see plenty of dangers ahead, including corporate debt levels, lofty valuations and inflation’s persistent grip.\nHere are the charts inducing nightmares on Wall Street:\nLucas Kawa, asset allocation strategist at UBS Asset Management:\n“The scariest chart in finance is the divergence between the market’s short-term expectations around Federal Reserve policy and long-term real rates. The yield on the 5th Eurodollar contract -- a proxy to gauge how much the U.S. central bank might tighten policy by December 2022, in this instance -- has risen by over 30 basis points in the last month. Meanwhile, 10-year real yields have retreated to near record lows below -1.1%, down almost 30 basis points over the same span. This combination of Fed expectations rising at least 25 basis points with 10-year real yields falling a minimum of 25 basis points over a rolling one-month period is extremely rare, occurring only one other time, in February 2009.”\n“Here are a few possible options, some of which are spookier than others: One, expectations regarding Fed tightening are too hawkish, and may be reversed by some mix of underwhelming activity data, cooling inflation, or central bank communications. Two, the fixed income market doesn’t think the economy will remain resilient following these rate hikes, which may prove to be a policy mistake and cause a growth scare. That’s not an outcome the stock market appears to be ascribing too much probability to at the moment! And three, real yields may adjust upwards to acknowledge the strong runway for both growth and inflation this cycle. This would likely be positive for our preferred procyclical relative value equity positions. However, a disorderly rise in real yields could challenge equity valuations at the index level, and the growth-oriented, expensive segments of the market in particular.”\nDeepak Puri, chief investment officer at Americas at Deutsche Bank Wealth Management:\n“Bond markets appear to have finally reached a turning point after 40 years of yields being driven lower by a combination of falling inflation rates and accommodative central bank policy. Taking advantage of the loosening financial conditions, corporates have steadily increased the appetite for debt over time with a considerable increase during the Covid-19 pandemic in part supported by the Federal Reserve’s stopgap measures to protect markets. As we enter a new investment landscape where inflation is returning after a long absence and central banks are becoming hawkish almost in unison, what impact will a tighter rate cycle and higher yields have on corporate profitability and the all-round health of their balance sheets?”\n\nKatie Koch, co-head of fundamental equity within Goldman Sachs Asset Management:\n“Lead times -- the time between when a semiconductor is ordered and when it is delivered -- rose to a record of nearly 22 weeks in October, almost double pre-pandemic lead times. The pandemic has exposed the fragility of global supply chains, which is best illustrated by the global chip famine that has paralyzed industries, companies, and governments. Given how critical chips are to the advancement of technologies globally, we expect chip manufacturers to prioritize supply-chain resilience over efficiency by reshoring semiconductor production. It is worth noting that delays in chip delivery times moderated in October, which may suggest the chip shortage has peaked but there is a long road ahead for normalization.”\n\nBen Emons, strategist at Medley Global Advisors:\n“The U.S. inflation market is subject to ‘hot money.’ The Fed’s holdings of TIPs (Treasury inflation-protected securities) and retail assets invested in the largest TIP ETF show how much anxiety there is about inflation. That is also where the risk is when inflation does moderate next year, and that could lead to a dislocation of real interest rates.”\nSteve Sosnick, chief strategist at Interactive Brokers:\n“I’m calling this graph ‘What Happens to a Meme Deferred?’ It’s the combined market cap of 12 of the ‘OG’ meme stocks. I find it fascinating that even after they’ve faded from the market’s consciousness, they’ve been able to maintain a gain of nearly 300% year-to-date.”\n“If we add in HOOD and consider it a meme stock, the total market cap exceeds the old highs.” In comparison, he said, the combined market value of Dogecoin and Shiba Inu coins exceeds $50 billion.”\n\nKara Murphy, Chief Investment Officer of Kestra Investment Management:\n“The volatility in Bitcoin and other cryptocurrencies is about as spooky as they come, positively dwarfing the volatility seen in more traditional asset classes. The recent upswing has attracted much attention from investors who are eager to participate in the upside, yet may be tempted to ignore the potential risks. Investors would do well to remember the tricks that come with these treats.”\n\nSteve Chiavarone, portfolio manager and head of multi-asset solutions at Federated Hermes:\n“The 2021 scariest chart is … federal tax revenue and spending as % of GDP. Tax revenue as a percentage of GDP is currently 19.4% -- which is just a touch below an all-time high. Regardless of marginal rates or tax structure, the U.S. has never been able to generate tax revenues in excess of 20% of GDP -- a concept known as Hauser’s Law. Once tax revenues reach the 20% of GDP level, they historically have either led to more tax avoidance and/or a slowdown in economic activity that ultimately pushes revenues lower. At the same time, government spending of 32.9% of GDP is the highest since WWII, with no real signs of abating given current negotiations over further large spending bills. Together these raise the ‘spooky’ possibility of further upward pressure on inflation via profligate spending alongside tax proposals that could, at the same time, disincentivize investment and hurt both shorter- and longer-term growth prospects.”\n\nLiz Ann Sonders, Charles Schwab’s chief investment strategist:\n“Never before has the stock market been valued as much as it is today relative to the size of the total economy; which suggests the stock market has never been more important as an economic driver as it is today.”\n\nMarlena Lee, global head of investment solutions at Dimensional Fund Advisors:\n“This Halloween, beware of investment funds in ‘green’ costumes. Investors searching for portfolios reflecting concerns about climate change may find ESG labels more trick than treat. One in four funds branded as ‘sustainability focused’ show less than 7% reduction in exposure to greenhouse gas (GHG) emissions intensity in comparison to the exposure of the broad market Russell 3000 index. This may be spooky for investors assuming ESG labeling to be a reliable indicator of less exposure to GHG-emitting companies.”\nRoss Mayfield, investment strategy analyst at Baird:\n“Amid the Covid-19 outbreak and subsequent stock market crash, investors piled into money market funds. However, 18 months and one historic rally later, cash on the sidelines remains elevated. Not only is cash earning next to nothing at a time when inflationary pressure is weighing on real returns, but getting back into an equity market near all-time highs is psychologically challenging (particularly one that has presented just a single -5% dip in the last year). It’s scary to think about the double-sided impact this could have on savers and investors long-term.”\n\nWes Crill, head of investment strategists at Dimensional Fund Advisors:\n“Investors expecting momentum strategies to diversify their value exposure may be spooked by the potential overlap between these two. Combining momentum and value strategies may inadvertently double down on one’s value tilt, a scary proposition for those wanting consistent exposure to value. Stocks with high profitability have had a more consistently low overlap with value, the two complementing each other like candy and corn.”","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1521,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854824179,"gmtCreate":1635434618523,"gmtModify":1635434619054,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854824179","repostId":"1173352835","repostType":4,"isVote":1,"tweetType":1,"viewCount":1630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856750366,"gmtCreate":1635215471018,"gmtModify":1635215471568,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856750366","repostId":"2178147539","repostType":4,"isVote":1,"tweetType":1,"viewCount":1372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851680358,"gmtCreate":1634902931655,"gmtModify":1634902992675,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/851680358","repostId":"1101284007","repostType":4,"isVote":1,"tweetType":1,"viewCount":1428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859761016,"gmtCreate":1634736548790,"gmtModify":1634736552632,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859761016","repostId":"1139065544","repostType":4,"repost":{"id":"1139065544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634731709,"share":"https://ttm.financial/m/news/1139065544?lang=&edition=full","pubTime":"2021-10-20 20:08","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1139065544","media":"Tiger Newspress","summary":"US index futures were little changed as investors weighed the start of the earnings season against g","content":"<p>US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy</p>\n<p>crisis.&nbsp;</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&amp;P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.<img src=\"https://static.tigerbbs.com/69fa6d32c1b1d5935b3f4750ce19cd71\" tg-width=\"287\" tg-height=\"117\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>United Airlines (UAL US) gains 2% in U.S.&nbsp;premarket&nbsp;trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September</li>\n <li>Novavax (NVAX US) shares fall as much as 25% in U.S.&nbsp;premarket&nbsp;trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels</li>\n <li>Vinco Ventures (BBIG US) shares slump 15% in&nbsp;premarket&nbsp;trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman</li>\n <li>Ford (F US) shares gain 1.7%&nbsp;premarket&nbsp;after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year</li>\n <li>Stride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate</li>\n <li>WD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate</li>\n <li>Omnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates</li>\n <li>Canadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate</li>\n <li>Akero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S</li>\n</ul>\n<p>In rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,</p>\n<p>where short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength.&nbsp;</p>\n<p>In commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.</p>\n<p>In cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-20 20:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy</p>\n<p>crisis.&nbsp;</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&amp;P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.<img src=\"https://static.tigerbbs.com/69fa6d32c1b1d5935b3f4750ce19cd71\" tg-width=\"287\" tg-height=\"117\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>United Airlines (UAL US) gains 2% in U.S.&nbsp;premarket&nbsp;trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September</li>\n <li>Novavax (NVAX US) shares fall as much as 25% in U.S.&nbsp;premarket&nbsp;trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels</li>\n <li>Vinco Ventures (BBIG US) shares slump 15% in&nbsp;premarket&nbsp;trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman</li>\n <li>Ford (F US) shares gain 1.7%&nbsp;premarket&nbsp;after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year</li>\n <li>Stride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate</li>\n <li>WD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate</li>\n <li>Omnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates</li>\n <li>Canadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate</li>\n <li>Akero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S</li>\n</ul>\n<p>In rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,</p>\n<p>where short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength.&nbsp;</p>\n<p>In commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.</p>\n<p>In cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UAL":"联合大陆航空","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139065544","content_text":"US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy\ncrisis. \nAt 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.\n\nUnited Airlines (UAL US) gains 2% in U.S. premarket trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September\nNovavax (NVAX US) shares fall as much as 25% in U.S. premarket trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels\nVinco Ventures (BBIG US) shares slump 15% in premarket trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman\nFord (F US) shares gain 1.7% premarket after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year\nStride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate\nWD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate\nOmnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates\nCanadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate\nAkero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S\n\nIn rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,\nwhere short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength. \nIn commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.\nIn cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.","news_type":1,"symbols_score_info":{"NVAX":0.9,"UAL":0.9}},"isVote":1,"tweetType":1,"viewCount":1207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823664948,"gmtCreate":1633618943184,"gmtModify":1633618943793,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823664948","repostId":"2173497159","repostType":4,"repost":{"id":"2173497159","kind":"highlight","pubTimestamp":1633606500,"share":"https://ttm.financial/m/news/2173497159?lang=&edition=full","pubTime":"2021-10-07 19:35","market":"us","language":"en","title":"Charlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173497159","media":"Motley Fool","summary":"Charlie Munger was greedy when others were fearful over China and Alibaba this summer.","content":"<p>In a recent regulatory filing, <b>The <a href=\"https://laohu8.com/S/DJCO\">Daily Journal</a></b> disclosed that it had bought more shares of Chinese giant <b><a href=\"https://laohu8.com/S/BABA\">Alibaba</a></b> with its corporate cash. The decision was probably the work of Charlie Munger, Warren Buffett's partner and <b><a href=\"https://laohu8.com/S/BRK.A\">Berkshire Hathaway</a></b> vice chairman. Munger is also the chairman of The Daily Journal and holds 3.6% of the company's shares.</p>\n<p>Although The Daily Journal started off as a legal newspaper and is now transitioning to become a software company to local court systems, it uses its cash holdings to invest in equities, which make up a significant portion of the company's market cap.</p>\n<p>While The Daily Journal's concentrated portfolio consists mainly of large U.S. banks, in the first quarter, Munger, a longtime <a href=\"https://laohu8.com/S/CAAS\">China</a> bull, bought a stake in <a href=\"https://laohu8.com/S/09988\">Alibaba</a>. With that investment having gone south this summer, The Daily Journal's recent disclosure shows Munger nearly doubling down on his bet as Alibaba's share price plummeted.</p>\n<p><img src=\"https://static.tigerbbs.com/1b1161f51c34685fdb339ca2519e8fbc\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>Still believing in BABA</h3>\n<p>In the filing, The Daily Journal disclosed that its stake in Alibaba had risen from 165,320 shares at the end of the first quarter to 302,060 shares at the end of Q3. That's an 83% increase -- a near doubling of Munger's bet. The company's stake in Alibaba now totals about $45 million -- good for about 20% of the Daily Journal's portfolio.</p>\n<p>It has been a rough year for Alibaba's stock, as shares are down 38.5% on the year and a whopping 56.3% from all-time highs set back in 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/fc3631e8a8bdb0723f45707ca1878a64\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>BABA data by YCharts</p>\n<p>As Munger is a noted value investor, if he believed Alibaba was a cheap stock back in April, when shares where in the $230-$240 per share range, he probably loves it now, with the stock currently trading in the $140s. It's a prime example of adhering to partner Warren Buffett's famous quote: \"Be fearful when others are greedy, and greedy when others are fearful.\"</p>\n<h3>But should you follow Munger into Alibaba?</h3>\n<p>If you're investing your own money, as a general rule, it's usually best not to blindly follow others into an investment, even if they're famous investors. Famous investors can make mistakes, too, and if a trade goes south and you don't know <i>why</i> you own something, you may panic and sell at the wrong time.</p>\n<p>Alibaba is a fascinating case, of course, as there are plenty of valid reasons for an investor to be both bullish or bearish at this time of great uncertainty.</p>\n<p><img src=\"https://static.tigerbbs.com/f41181175cea4ae5ef058c33c860564a\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The bull case on BABA: It looks very cheap</h3>\n<p>On the bullish side, Alibaba is of course a leading player in Chinese e-commerce, payments and fintech, and the cloud. With an entrenched position in these three high-growth areas, and given that Munger is known to be bullish on the long-term growth prospects of China and its rising middle class, it seems a pretty safe bet that Alibaba should grow in the years ahead.</p>\n<p>So when the IPO of Alibaba subsidiary Ant Financial was stopped a year ago and its stock fell, Munger swooped in, buying shares when Alibaba's P/E ratio fell to the high 20s. However, Alibaba also had about $135 billion in net cash and other investments in other companies at that time, so the \"core\" business was actually much cheaper than that. And Alibaba also has several promising but loss-making subsidiaries, such as its cloud computing platform, which probably has significant positive value but contributes negatively to current earnings.</p>\n<p>Over the summer, Alibaba's valuation has fallen all the way to just 17.3 times trailing earnings. That's <i>extremely</i> cheap, especially considering, again, Alibaba's prodigious cash holdings and investments, as well as several loss-making business segments. And even with all the negativity in Alibaba's stock today, analysts still estimate future growth, albeit more muted. Based on 2023 estimates, Alibaba trades at only 13.3 times earnings.</p>\n<h3>Reasons to be bearish: slowing growth and increased regulations</h3>\n<p>However, Munger may have misjudged the extent that Alibaba and other Chinese tech companies were to be punished. After a $2.8 billion fine for violating antimonopoly rules in e-commerce back in April, regulators have continued to issue regulations on delivery worker pay as well as restrictions on data collection, which could broadly affect Alibaba's portfolio of businesses.</p>\n<p>Ant Financial may be broken up into three separate businesses, effectively knocking down the company's moat against rivals. Even on the core business, recent regulations could open Alibaba's main cash cow e-commerce business to more fierce competition.</p>\n<p>In August, its earnings report for the quarter ending in June revealed that it was light on revenue, disappointing some investors. While headline revenue grew 34%, outside of a large acquisition, revenue grew just 22% -- still a solid figure, but a deceleration from Alibaba's past rate. Recent troubles at <b>Evergrande</b> (OTC:EGRN.F), the large Chinese real estate developer, may still spill over into the broader Chinese economy. That could affect the Chinese consumer, which means less buying and lower revenue for Alibaba.</p>\n<p>Finally, Alibaba also recently announced a $15.5 billion \"social equity\" fund to tackle societal challenges such as gig-worker welfare, rural area development, and the growth of small and medium-sized businesses. That fund doesn't necessarily have a financial payoff.</p>\n<p>Finally, U.S.-China relations have been frosty to say the least, and further tensions could cause China to take unilateral actions against foreign shareholders of domestic companies. Alibaba is listed in the U.S., but because of Chinese rules, non-Chinese shareholders don't directly own shares, but rather shares of a variable interest entity (VIE) listed in the Cayman Islands, which has a contractual right to part of Alibaba's business. Should things go south between the two countries, it's possible -- a long shot, but still possible -- that China may look to take aim at the VIE structure and contracts.</p>\n<h3>Factor these things in when looking to buy Alibaba</h3>\n<p>Munger has long been positive on the growth of China, and it's safe to say he knows an awful lot about the country. However, there are also other smart people with a more pessimistic view of China.</p>\n<p>In buying Alibaba, investors need to have confidence the current regulatory campaign will eventually stop or moderate, and that Alibaba will still be able to function as a relatively normal profit-making company -- albeit with more regulations. Obviously, Munger believes that will happen after this period of turbulence, but it's by no means a sure thing.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 19:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In a recent regulatory filing, The Daily Journal disclosed that it had bought more shares of Chinese giant Alibaba with its corporate cash. The decision was probably the work of Charlie Munger, Warren...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISBC":"投资者银行","BABA":"阿里巴巴","DJCO":"每日期刊"},"source_url":"https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173497159","content_text":"In a recent regulatory filing, The Daily Journal disclosed that it had bought more shares of Chinese giant Alibaba with its corporate cash. The decision was probably the work of Charlie Munger, Warren Buffett's partner and Berkshire Hathaway vice chairman. Munger is also the chairman of The Daily Journal and holds 3.6% of the company's shares.\nAlthough The Daily Journal started off as a legal newspaper and is now transitioning to become a software company to local court systems, it uses its cash holdings to invest in equities, which make up a significant portion of the company's market cap.\nWhile The Daily Journal's concentrated portfolio consists mainly of large U.S. banks, in the first quarter, Munger, a longtime China bull, bought a stake in Alibaba. With that investment having gone south this summer, The Daily Journal's recent disclosure shows Munger nearly doubling down on his bet as Alibaba's share price plummeted.\n\nImage source: Getty Images.\nStill believing in BABA\nIn the filing, The Daily Journal disclosed that its stake in Alibaba had risen from 165,320 shares at the end of the first quarter to 302,060 shares at the end of Q3. That's an 83% increase -- a near doubling of Munger's bet. The company's stake in Alibaba now totals about $45 million -- good for about 20% of the Daily Journal's portfolio.\nIt has been a rough year for Alibaba's stock, as shares are down 38.5% on the year and a whopping 56.3% from all-time highs set back in 2020.\n\nBABA data by YCharts\nAs Munger is a noted value investor, if he believed Alibaba was a cheap stock back in April, when shares where in the $230-$240 per share range, he probably loves it now, with the stock currently trading in the $140s. It's a prime example of adhering to partner Warren Buffett's famous quote: \"Be fearful when others are greedy, and greedy when others are fearful.\"\nBut should you follow Munger into Alibaba?\nIf you're investing your own money, as a general rule, it's usually best not to blindly follow others into an investment, even if they're famous investors. Famous investors can make mistakes, too, and if a trade goes south and you don't know why you own something, you may panic and sell at the wrong time.\nAlibaba is a fascinating case, of course, as there are plenty of valid reasons for an investor to be both bullish or bearish at this time of great uncertainty.\n\nImage source: Getty Images.\nThe bull case on BABA: It looks very cheap\nOn the bullish side, Alibaba is of course a leading player in Chinese e-commerce, payments and fintech, and the cloud. With an entrenched position in these three high-growth areas, and given that Munger is known to be bullish on the long-term growth prospects of China and its rising middle class, it seems a pretty safe bet that Alibaba should grow in the years ahead.\nSo when the IPO of Alibaba subsidiary Ant Financial was stopped a year ago and its stock fell, Munger swooped in, buying shares when Alibaba's P/E ratio fell to the high 20s. However, Alibaba also had about $135 billion in net cash and other investments in other companies at that time, so the \"core\" business was actually much cheaper than that. And Alibaba also has several promising but loss-making subsidiaries, such as its cloud computing platform, which probably has significant positive value but contributes negatively to current earnings.\nOver the summer, Alibaba's valuation has fallen all the way to just 17.3 times trailing earnings. That's extremely cheap, especially considering, again, Alibaba's prodigious cash holdings and investments, as well as several loss-making business segments. And even with all the negativity in Alibaba's stock today, analysts still estimate future growth, albeit more muted. Based on 2023 estimates, Alibaba trades at only 13.3 times earnings.\nReasons to be bearish: slowing growth and increased regulations\nHowever, Munger may have misjudged the extent that Alibaba and other Chinese tech companies were to be punished. After a $2.8 billion fine for violating antimonopoly rules in e-commerce back in April, regulators have continued to issue regulations on delivery worker pay as well as restrictions on data collection, which could broadly affect Alibaba's portfolio of businesses.\nAnt Financial may be broken up into three separate businesses, effectively knocking down the company's moat against rivals. Even on the core business, recent regulations could open Alibaba's main cash cow e-commerce business to more fierce competition.\nIn August, its earnings report for the quarter ending in June revealed that it was light on revenue, disappointing some investors. While headline revenue grew 34%, outside of a large acquisition, revenue grew just 22% -- still a solid figure, but a deceleration from Alibaba's past rate. Recent troubles at Evergrande (OTC:EGRN.F), the large Chinese real estate developer, may still spill over into the broader Chinese economy. That could affect the Chinese consumer, which means less buying and lower revenue for Alibaba.\nFinally, Alibaba also recently announced a $15.5 billion \"social equity\" fund to tackle societal challenges such as gig-worker welfare, rural area development, and the growth of small and medium-sized businesses. That fund doesn't necessarily have a financial payoff.\nFinally, U.S.-China relations have been frosty to say the least, and further tensions could cause China to take unilateral actions against foreign shareholders of domestic companies. Alibaba is listed in the U.S., but because of Chinese rules, non-Chinese shareholders don't directly own shares, but rather shares of a variable interest entity (VIE) listed in the Cayman Islands, which has a contractual right to part of Alibaba's business. Should things go south between the two countries, it's possible -- a long shot, but still possible -- that China may look to take aim at the VIE structure and contracts.\nFactor these things in when looking to buy Alibaba\nMunger has long been positive on the growth of China, and it's safe to say he knows an awful lot about the country. However, there are also other smart people with a more pessimistic view of China.\nIn buying Alibaba, investors need to have confidence the current regulatory campaign will eventually stop or moderate, and that Alibaba will still be able to function as a relatively normal profit-making company -- albeit with more regulations. Obviously, Munger believes that will happen after this period of turbulence, but it's by no means a sure thing.","news_type":1,"symbols_score_info":{"BABA":0.9,"DJCO":0.9,"ISBC":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865732815,"gmtCreate":1633017160194,"gmtModify":1633017160599,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865732815","repostId":"1164073079","repostType":4,"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862927814,"gmtCreate":1632832329644,"gmtModify":1632832329750,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Hohoho&nbsp;","listText":"Hohoho&nbsp;","text":"Hohoho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862927814","repostId":"1126986798","repostType":4,"repost":{"id":"1126986798","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632827257,"share":"https://ttm.financial/m/news/1126986798?lang=&edition=full","pubTime":"2021-09-28 19:07","market":"us","language":"en","title":"Sonoma Pharmaceuticals shares surged 45% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1126986798","media":"Tiger Newspress","summary":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou","content":"<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals shares surged 45% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals shares surged 45% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 19:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOA":"Sonoma Pharmaceuticals, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126986798","content_text":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.\n\nSonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.\nSonoma offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.\nRegenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.\nOcucyn Eyelid & Eyelash Cleanser, designed for everyday use, is a safe, gentle & effective solution for good eyelid & eyelash hygiene. Ocucyn Eyelid & Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid & Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.\nMucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.\nAbout Sonoma Pharmaceuticals, Inc.\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.","news_type":1,"symbols_score_info":{"SNOA":0.9}},"isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868590977,"gmtCreate":1632667310399,"gmtModify":1632798692237,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868590977","repostId":"1175726457","repostType":4,"repost":{"id":"1175726457","kind":"news","pubTimestamp":1632626757,"share":"https://ttm.financial/m/news/1175726457?lang=&edition=full","pubTime":"2021-09-26 11:25","market":"hk","language":"en","title":"Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell","url":"https://stock-news.laohu8.com/highlight/detail?id=1175726457","media":"Market Watch","summary":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for tw","content":"<p>It’s an urgent question, since the <a href=\"https://laohu8.com/S/C\">Citigroup</a> Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.</p>\n<p>Is it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?</p>\n<p>The latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. <a href=\"https://laohu8.com/S/JE\">Just</a> 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.</p>\n<p><img src=\"https://static.tigerbbs.com/dd20c01571a824c8113089a65b814bb3\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>There is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.</p>\n<p>To help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&amp;P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> year. I came up with nothing that met traditional standards of statistical significance.</p>\n<p>A summary of what I found is plotted in the chart below. Notice that the S&amp;P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.</p>\n<p><img src=\"https://static.tigerbbs.com/65016b28c482526ac92a5d6035ba9ed9\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>These findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”</p>\n<p>There’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.</p>\n<p>It can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-26 11:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175726457","content_text":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.\nIs it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?\nThe latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. Just 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.\n\nThere is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.\nTo help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and one year. I came up with nothing that met traditional standards of statistical significance.\nA summary of what I found is plotted in the chart below. Notice that the S&P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.\n\nThese findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”\nThere’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.\nIt can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":640,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863541152,"gmtCreate":1632408078476,"gmtModify":1632731087207,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Niceee","listText":"Niceee","text":"Niceee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/863541152","repostId":"2169664162","repostType":4,"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887537834,"gmtCreate":1632062084628,"gmtModify":1632803073363,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887537834","repostId":"1198486138","repostType":4,"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884076553,"gmtCreate":1631843037872,"gmtModify":1631889028803,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/884076553","repostId":"2168542123","repostType":4,"repost":{"id":"2168542123","kind":"news","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=full","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FANG":"Diamondback Energy","X":"美国钢铁","GRTS":"Gritstone Oncology Inc.","ABCL":"AbCellera Biologics"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1,"symbols_score_info":{"ABCL":0.9,"FANG":0.9,"GRTS":0.9,"X":0.9}},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881579729,"gmtCreate":1631371144761,"gmtModify":1631889648214,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/881579729","repostId":"1105074635","repostType":4,"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812565508,"gmtCreate":1630595310804,"gmtModify":1631889648219,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Awesome&nbsp;","listText":"Awesome&nbsp;","text":"Awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812565508","repostId":"1146170136","repostType":4,"isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813782061,"gmtCreate":1630248450153,"gmtModify":1704957438171,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/813782061","repostId":"1129129956","repostType":4,"repost":{"id":"1129129956","kind":"news","pubTimestamp":1630201285,"share":"https://ttm.financial/m/news/1129129956?lang=&edition=full","pubTime":"2021-08-29 09:41","market":"us","language":"en","title":"This Unloved Tech Stock Could Make You Rich One Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1129129956","media":"Motley Fool","summary":"The iBuying business is a race to grow larger, and Opendoor is winning.The company is growing at a rate that is two years ahead of what management projected just a year earlier.The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.Real estate iBuying company Opendoor Technologieshas been executing at a high level in the three quarters since coming public via a special purpose acquisition company  merger. In a race to disrupt residential ","content":"<p>Key Points</p>\n<ul>\n <li>The iBuying business is a race to grow larger, and Opendoor is winning.</li>\n <li>The company is growing at a rate that is two years ahead of what management projected just a year earlier.</li>\n <li>The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.</li>\n</ul>\n<p></p>\n<p>Real estate iBuying company&nbsp;<b>Opendoor Technologies</b>(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.</p>\n<p>Despite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.</p>\n<h3>1. Opendoor is winning the iBuying battle</h3>\n<p>The traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.</p>\n<p>Opendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.</p>\n<p>After seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including&nbsp;<b>Zillow Group</b>&nbsp;and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.</p>\n<p>According to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.</p>\n<h3>2. Revenue growth is ahead of schedule</h3>\n<p>When companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.</p>\n<p>Fast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"</p>\n<p>In other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.</p>\n<h3>3. SPACs are out of favor with the market... opportunity?</h3>\n<p>Investors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.</p>\n<p>Investors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.</p>\n<p>But if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.</p>\n<p>Competitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.</p>\n<h3>Here's the bottom line</h3>\n<p>Real estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"<b>Amazon</b>\" of home buying, but what seems certain is that the company is&nbsp;poised to be a big player&nbsp;in real estate's future if it keeps performing like this.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Unloved Tech Stock Could Make You Rich One Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unloved Tech Stock Could Make You Rich One Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-29 09:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPEN":"Opendoor Technologies Inc"},"source_url":"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129129956","content_text":"Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.\n\n\nReal estate iBuying company Opendoor Technologies(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.\nDespite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.\n1. Opendoor is winning the iBuying battle\nThe traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.\nOpendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.\nAfter seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including Zillow Group and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.\nAccording to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.\n2. Revenue growth is ahead of schedule\nWhen companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.\nFast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"\nIn other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.\n3. SPACs are out of favor with the market... opportunity?\nInvestors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.\nInvestors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.\nBut if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.\nCompetitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.\nHere's the bottom line\nReal estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"Amazon\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.","news_type":1,"symbols_score_info":{"OPEN":0.9}},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":166531188,"gmtCreate":1624016557144,"gmtModify":1634024088244,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Nicee","listText":"Nicee","text":"Nicee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/166531188","repostId":"1133025835","repostType":4,"repost":{"id":"1133025835","kind":"news","pubTimestamp":1624015886,"share":"https://ttm.financial/m/news/1133025835?lang=&edition=full","pubTime":"2021-06-18 19:31","market":"us","language":"en","title":"Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy","url":"https://stock-news.laohu8.com/highlight/detail?id=1133025835","media":"cnbc","summary":"The demand outlook for Biogen’s new Alzheimer’s drug appears strong despite lingering concerns about","content":"<div>\n<p>The demand outlook for Biogen’s new Alzheimer’s drug appears strong despite lingering concerns about the new treatment, and that should push the company’s stock higher, according to Piper Sandler.\nThe...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/piper-sandler-upgrades-biogen-says-alzheimers-drug-demand-will-be-strong-despite-controversy.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPiper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 19:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/18/piper-sandler-upgrades-biogen-says-alzheimers-drug-demand-will-be-strong-despite-controversy.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The demand outlook for Biogen’s new Alzheimer’s drug appears strong despite lingering concerns about the new treatment, and that should push the company’s stock higher, according to Piper Sandler.\nThe...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/piper-sandler-upgrades-biogen-says-alzheimers-drug-demand-will-be-strong-despite-controversy.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.cnbc.com/2021/06/18/piper-sandler-upgrades-biogen-says-alzheimers-drug-demand-will-be-strong-despite-controversy.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1133025835","content_text":"The demand outlook for Biogen’s new Alzheimer’s drug appears strong despite lingering concerns about the new treatment, and that should push the company’s stock higher, according to Piper Sandler.\nThe Food and Drug Administration’s approval of Aduhelm has been controversial, with multiple members of an FDA advisory committeeresigning in protestover the decision. There are concerns about the effectiveness of the treatment.\nPiper Sandler analyst Christopher Raymond said in a note to clients on Friday that he shared some of those concerns but that Aduhelm would still be a winner for Biogen’s business. Raymond upgraded the stock to overweight from neutral.\n“Despite our misgivings regarding FDA’s handling of the Aduhelm approval, we find two new data points too positive to ignore, and thus believe the path of least resistance on this stock is decidedly higher,” the note said.\nThose positive data points include a survey that shows strong demand and expected uptake for the drug, despite concerns about its effectiveness, and an expectation that Medicare and Medicaid will not significantly limit the available patient base for reimbursement, Piper Sandler said.\n“Combining this with what we see as a low-probability but still completely free call option that Biogen wins on appeal with the Tecfidera IP case, we think the stock is likely to go higher in the near term,” the note said.\nThe firm hiked its price target to $450 from $384, representing upside of 17% from where the stock closed on Thursday.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":849544565,"gmtCreate":1635770093075,"gmtModify":1635770093291,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849544565","repostId":"1121087038","repostType":4,"isVote":1,"tweetType":1,"viewCount":1580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":804042950,"gmtCreate":1627913721070,"gmtModify":1631889648229,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Niceeeee","listText":"Niceeeee","text":"Niceeeee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/804042950","repostId":"1155693481","repostType":4,"repost":{"id":"1155693481","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627913458,"share":"https://ttm.financial/m/news/1155693481?lang=&edition=full","pubTime":"2021-08-02 22:10","market":"us","language":"en","title":"Tesla rose nearly 5% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1155693481","media":"Tiger Newspress","summary":" $Tesla Motors$ rose nearly 5% in morning trading.Elon Musk confirms Tesla AI Day will be on August 19.In addition ,Last Thursday, Benzinga Proalerted its users Tesla hadfiled a patentthat would allow it to recover and recycle nickel and cobalt from old lithium-ion EV batteries.The patent, titled “Metal Sulfate Manufacturing System via Electrochemical Dissolution,” would allow the EV and technology company to recover the two crucial raw battery metals and reuse them making its supply chain more ","content":"<p>(August 2)&nbsp;<a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> rose nearly 5% in morning trading.</p>\n<p>Elon Musk confirms Tesla AI Day will be on August 19.</p>\n<p>In&nbsp;addition&nbsp;,Last Thursday,&nbsp;Benzinga Proalerted its users Tesla hadfiled a patentthat would allow it to recover and recycle nickel and cobalt from old lithium-ion EV batteries.</p>\n<p>The patent, titled “Metal Sulfate Manufacturing System via Electrochemical Dissolution,” would allow the EV and technology company to recover the two crucial raw battery metals and reuse them making its supply chain more efficient.</p>\n<p><img src=\"https://static.tigerbbs.com/9faf5c64c1d04f0efe8c72c78addc130\" tg-width=\"725\" tg-height=\"633\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla rose nearly 5% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla rose nearly 5% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(August 2)&nbsp;<a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> rose nearly 5% in morning trading.</p>\n<p>Elon Musk confirms Tesla AI Day will be on August 19.</p>\n<p>In&nbsp;addition&nbsp;,Last Thursday,&nbsp;Benzinga Proalerted its users Tesla hadfiled a patentthat would allow it to recover and recycle nickel and cobalt from old lithium-ion EV batteries.</p>\n<p>The patent, titled “Metal Sulfate Manufacturing System via Electrochemical Dissolution,” would allow the EV and technology company to recover the two crucial raw battery metals and reuse them making its supply chain more efficient.</p>\n<p><img src=\"https://static.tigerbbs.com/9faf5c64c1d04f0efe8c72c78addc130\" tg-width=\"725\" tg-height=\"633\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155693481","content_text":"(August 2) Tesla Motors rose nearly 5% in morning trading.\nElon Musk confirms Tesla AI Day will be on August 19.\nIn addition ,Last Thursday, Benzinga Proalerted its users Tesla hadfiled a patentthat would allow it to recover and recycle nickel and cobalt from old lithium-ion EV batteries.\nThe patent, titled “Metal Sulfate Manufacturing System via Electrochemical Dissolution,” would allow the EV and technology company to recover the two crucial raw battery metals and reuse them making its supply chain more efficient.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":857691252,"gmtCreate":1635520627145,"gmtModify":1635520627300,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857691252","repostId":"1138275414","repostType":4,"repost":{"id":"1138275414","kind":"news","pubTimestamp":1635513832,"share":"https://ttm.financial/m/news/1138275414?lang=&edition=full","pubTime":"2021-10-29 21:23","market":"us","language":"en","title":"Charts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1138275414","media":"Bloomberg","summary":"Halloween -- a time when terrifying things pop out from around every corner but none do you harm. Th","content":"<p>Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.</p>\n<p>It hasn’t escaped Wall Street that 2021 has been mostly treats and no tricks, with the S&amp;P 500 up 22% so far. But investors see plenty of dangers ahead, including corporate debt levels, lofty valuations and inflation’s persistent grip.</p>\n<p>Here are the charts inducing nightmares on Wall Street:</p>\n<p>Lucas Kawa, asset allocation strategist at UBS Asset Management:</p>\n<p>“The scariest chart in finance is the divergence between the market’s short-term expectations around Federal Reserve policy and long-term real rates. The yield on the 5th Eurodollar contract -- a proxy to gauge how much the U.S. central bank might tighten policy by December 2022, in this instance -- has risen by over 30 basis points in the last month. Meanwhile, 10-year real yields have retreated to near record lows below -1.1%, down almost 30 basis points over the same span. This combination of Fed expectations rising at least 25 basis points with 10-year real yields falling a minimum of 25 basis points over a rolling one-month period is extremely rare, occurring only one other time, in February 2009.”</p>\n<p><img src=\"https://static.tigerbbs.com/edb31ff1f84a03fb8269077437d7da8f\" tg-width=\"1200\" tg-height=\"707\" width=\"100%\" height=\"auto\">“Here are a few possible options, some of which are spookier than others: One, expectations regarding Fed tightening are too hawkish, and may be reversed by some mix of underwhelming activity data, cooling inflation, or central bank communications. Two, the fixed income market doesn’t think the economy will remain resilient following these rate hikes, which may prove to be a policy mistake and cause a growth scare. That’s not an outcome the stock market appears to be ascribing too much probability to at the moment! And three, real yields may adjust upwards to acknowledge the strong runway for both growth and inflation this cycle. This would likely be positive for our preferred procyclical relative value equity positions. However, a disorderly rise in real yields could challenge equity valuations at the index level, and the growth-oriented, expensive segments of the market in particular.”</p>\n<p>Deepak Puri, chief investment officer at Americas at Deutsche Bank Wealth Management:</p>\n<p>“Bond markets appear to have finally reached a turning point after 40 years of yields being driven lower by a combination of falling inflation rates and accommodative central bank policy. Taking advantage of the loosening financial conditions, corporates have steadily increased the appetite for debt over time with a considerable increase during the Covid-19 pandemic in part supported by the Federal Reserve’s stopgap measures to protect markets. As we enter a new investment landscape where inflation is returning after a long absence and central banks are becoming hawkish almost in unison, what impact will a tighter rate cycle and higher yields have on corporate profitability and the all-round health of their balance sheets?”</p>\n<p><img src=\"https://static.tigerbbs.com/917c68634fca6219a21635daa969ec3d\" tg-width=\"1200\" tg-height=\"724\" width=\"100%\" height=\"auto\"></p>\n<p>Katie Koch, co-head of fundamental equity within Goldman Sachs Asset Management:</p>\n<p>“Lead times -- the time between when a semiconductor is ordered and when it is delivered -- rose to a record of nearly 22 weeks in October, almost double pre-pandemic lead times. The pandemic has exposed the fragility of global supply chains, which is best illustrated by the global chip famine that has paralyzed industries, companies, and governments. Given how critical chips are to the advancement of technologies globally, we expect chip manufacturers to prioritize supply-chain resilience over efficiency by reshoring semiconductor production. It is worth noting that delays in chip delivery times moderated in October, which may suggest the chip shortage has peaked but there is a long road ahead for normalization.”</p>\n<p><img src=\"https://static.tigerbbs.com/065a99b9847793a19c545d407054ed0e\" tg-width=\"1200\" tg-height=\"646\" width=\"100%\" height=\"auto\"></p>\n<p>Ben Emons, strategist at Medley Global Advisors:</p>\n<p>“The U.S. inflation market is subject to ‘hot money.’ The Fed’s holdings of TIPs (Treasury inflation-protected securities) and retail assets invested in the largest TIP ETF show how much anxiety there is about inflation. That is also where the risk is when inflation does moderate next year, and that could lead to a dislocation of real interest rates.”</p>\n<p><img src=\"https://static.tigerbbs.com/598faca2b2e6631bdabe998c8b809600\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\">Steve Sosnick, chief strategist at Interactive Brokers:</p>\n<p>“I’m calling this graph ‘What Happens to a Meme Deferred?’ It’s the combined market cap of 12 of the ‘OG’ meme stocks. I find it fascinating that even after they’ve faded from the market’s consciousness, they’ve been able to maintain a gain of nearly 300% year-to-date.”</p>\n<p>“If we add in HOOD and consider it a meme stock, the total market cap exceeds the old highs.” In comparison, he said, the combined market value of Dogecoin and Shiba Inu coins exceeds $50 billion.”</p>\n<p><img src=\"https://static.tigerbbs.com/b79e8394a6298f1dfd985fc23caad350\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Kara Murphy, Chief Investment Officer of Kestra Investment Management:</p>\n<p>“The volatility in Bitcoin and other cryptocurrencies is about as spooky as they come, positively dwarfing the volatility seen in more traditional asset classes. The recent upswing has attracted much attention from investors who are eager to participate in the upside, yet may be tempted to ignore the potential risks. Investors would do well to remember the tricks that come with these treats.”</p>\n<p><img src=\"https://static.tigerbbs.com/bc2efb02417527c7876c435593d328cb\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Steve Chiavarone, portfolio manager and head of multi-asset solutions at Federated Hermes:</p>\n<p>“The 2021 scariest chart is … federal tax revenue and spending as % of GDP. Tax revenue as a percentage of GDP is currently 19.4% -- which is just a touch below an all-time high. Regardless of marginal rates or tax structure, the U.S. has never been able to generate tax revenues in excess of 20% of GDP -- a concept known as Hauser’s Law. Once tax revenues reach the 20% of GDP level, they historically have either led to more tax avoidance and/or a slowdown in economic activity that ultimately pushes revenues lower. At the same time, government spending of 32.9% of GDP is the highest since WWII, with no real signs of abating given current negotiations over further large spending bills. Together these raise the ‘spooky’ possibility of further upward pressure on inflation via profligate spending alongside tax proposals that could, at the same time, disincentivize investment and hurt both shorter- and longer-term growth prospects.”</p>\n<p><img src=\"https://static.tigerbbs.com/c558130d717a3355ff3686f7fe891931\" tg-width=\"1200\" tg-height=\"699\" width=\"100%\" height=\"auto\"></p>\n<p>Liz Ann Sonders, Charles Schwab’s chief investment strategist:</p>\n<p>“Never before has the stock market been valued as much as it is today relative to the size of the total economy; which suggests the stock market has never been more important as an economic driver as it is today.”</p>\n<p><img src=\"https://static.tigerbbs.com/a1d0952b2176148687569c525c7b69d9\" tg-width=\"1200\" tg-height=\"500\" width=\"100%\" height=\"auto\"></p>\n<p>Marlena Lee, global head of investment solutions at Dimensional Fund Advisors:</p>\n<p>“This Halloween, beware of investment funds in ‘green’ costumes. Investors searching for portfolios reflecting concerns about climate change may find ESG labels more trick than treat. One in four funds branded as ‘sustainability focused’ show less than 7% reduction in exposure to greenhouse gas (GHG) emissions intensity in comparison to the exposure of the broad market Russell 3000 index. This may be spooky for investors assuming ESG labeling to be a reliable indicator of less exposure to GHG-emitting companies.”<img src=\"https://static.tigerbbs.com/de0395a9c798571b5311ec7f38bd591f\" tg-width=\"1200\" tg-height=\"764\" width=\"100%\" height=\"auto\"></p>\n<p>Ross Mayfield, investment strategy analyst at Baird:</p>\n<p>“Amid the Covid-19 outbreak and subsequent stock market crash, investors piled into money market funds. However, 18 months and one historic rally later, cash on the sidelines remains elevated. Not only is cash earning next to nothing at a time when inflationary pressure is weighing on real returns, but getting back into an equity market near all-time highs is psychologically challenging (particularly one that has presented just a single -5% dip in the last year). It’s scary to think about the double-sided impact this could have on savers and investors long-term.”</p>\n<p><img src=\"https://static.tigerbbs.com/94e4838b203c2c5affd2631839be1cf8\" tg-width=\"1200\" tg-height=\"881\" width=\"100%\" height=\"auto\"></p>\n<p>Wes Crill, head of investment strategists at Dimensional Fund Advisors:</p>\n<p>“Investors expecting momentum strategies to diversify their value exposure may be spooked by the potential overlap between these two. Combining momentum and value strategies may inadvertently double down on one’s value tilt, a scary proposition for those wanting consistent exposure to value. Stocks with high profitability have had a more consistently low overlap with value, the two complementing each other like candy and corn.”</p>\n<p><img src=\"https://static.tigerbbs.com/6d29c10c022e7d500a26d11644780f89\" tg-width=\"1200\" tg-height=\"813\" width=\"100%\" height=\"auto\"></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharts Spooking Wall Street: Rate Bets, Debt Loads, Tardy Chips\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-29 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.\nIt hasn’t escaped Wall Street that 2021...</p>\n\n<a href=\"https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/charts-spooking-wall-street-rate-130734359.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138275414","content_text":"Halloween -- a time when terrifying things pop out from around every corner but none do you harm. That’s also a good way to describe markets at the end of 2021.\nIt hasn’t escaped Wall Street that 2021 has been mostly treats and no tricks, with the S&P 500 up 22% so far. But investors see plenty of dangers ahead, including corporate debt levels, lofty valuations and inflation’s persistent grip.\nHere are the charts inducing nightmares on Wall Street:\nLucas Kawa, asset allocation strategist at UBS Asset Management:\n“The scariest chart in finance is the divergence between the market’s short-term expectations around Federal Reserve policy and long-term real rates. The yield on the 5th Eurodollar contract -- a proxy to gauge how much the U.S. central bank might tighten policy by December 2022, in this instance -- has risen by over 30 basis points in the last month. Meanwhile, 10-year real yields have retreated to near record lows below -1.1%, down almost 30 basis points over the same span. This combination of Fed expectations rising at least 25 basis points with 10-year real yields falling a minimum of 25 basis points over a rolling one-month period is extremely rare, occurring only one other time, in February 2009.”\n“Here are a few possible options, some of which are spookier than others: One, expectations regarding Fed tightening are too hawkish, and may be reversed by some mix of underwhelming activity data, cooling inflation, or central bank communications. Two, the fixed income market doesn’t think the economy will remain resilient following these rate hikes, which may prove to be a policy mistake and cause a growth scare. That’s not an outcome the stock market appears to be ascribing too much probability to at the moment! And three, real yields may adjust upwards to acknowledge the strong runway for both growth and inflation this cycle. This would likely be positive for our preferred procyclical relative value equity positions. However, a disorderly rise in real yields could challenge equity valuations at the index level, and the growth-oriented, expensive segments of the market in particular.”\nDeepak Puri, chief investment officer at Americas at Deutsche Bank Wealth Management:\n“Bond markets appear to have finally reached a turning point after 40 years of yields being driven lower by a combination of falling inflation rates and accommodative central bank policy. Taking advantage of the loosening financial conditions, corporates have steadily increased the appetite for debt over time with a considerable increase during the Covid-19 pandemic in part supported by the Federal Reserve’s stopgap measures to protect markets. As we enter a new investment landscape where inflation is returning after a long absence and central banks are becoming hawkish almost in unison, what impact will a tighter rate cycle and higher yields have on corporate profitability and the all-round health of their balance sheets?”\n\nKatie Koch, co-head of fundamental equity within Goldman Sachs Asset Management:\n“Lead times -- the time between when a semiconductor is ordered and when it is delivered -- rose to a record of nearly 22 weeks in October, almost double pre-pandemic lead times. The pandemic has exposed the fragility of global supply chains, which is best illustrated by the global chip famine that has paralyzed industries, companies, and governments. Given how critical chips are to the advancement of technologies globally, we expect chip manufacturers to prioritize supply-chain resilience over efficiency by reshoring semiconductor production. It is worth noting that delays in chip delivery times moderated in October, which may suggest the chip shortage has peaked but there is a long road ahead for normalization.”\n\nBen Emons, strategist at Medley Global Advisors:\n“The U.S. inflation market is subject to ‘hot money.’ The Fed’s holdings of TIPs (Treasury inflation-protected securities) and retail assets invested in the largest TIP ETF show how much anxiety there is about inflation. That is also where the risk is when inflation does moderate next year, and that could lead to a dislocation of real interest rates.”\nSteve Sosnick, chief strategist at Interactive Brokers:\n“I’m calling this graph ‘What Happens to a Meme Deferred?’ It’s the combined market cap of 12 of the ‘OG’ meme stocks. I find it fascinating that even after they’ve faded from the market’s consciousness, they’ve been able to maintain a gain of nearly 300% year-to-date.”\n“If we add in HOOD and consider it a meme stock, the total market cap exceeds the old highs.” In comparison, he said, the combined market value of Dogecoin and Shiba Inu coins exceeds $50 billion.”\n\nKara Murphy, Chief Investment Officer of Kestra Investment Management:\n“The volatility in Bitcoin and other cryptocurrencies is about as spooky as they come, positively dwarfing the volatility seen in more traditional asset classes. The recent upswing has attracted much attention from investors who are eager to participate in the upside, yet may be tempted to ignore the potential risks. Investors would do well to remember the tricks that come with these treats.”\n\nSteve Chiavarone, portfolio manager and head of multi-asset solutions at Federated Hermes:\n“The 2021 scariest chart is … federal tax revenue and spending as % of GDP. Tax revenue as a percentage of GDP is currently 19.4% -- which is just a touch below an all-time high. Regardless of marginal rates or tax structure, the U.S. has never been able to generate tax revenues in excess of 20% of GDP -- a concept known as Hauser’s Law. Once tax revenues reach the 20% of GDP level, they historically have either led to more tax avoidance and/or a slowdown in economic activity that ultimately pushes revenues lower. At the same time, government spending of 32.9% of GDP is the highest since WWII, with no real signs of abating given current negotiations over further large spending bills. Together these raise the ‘spooky’ possibility of further upward pressure on inflation via profligate spending alongside tax proposals that could, at the same time, disincentivize investment and hurt both shorter- and longer-term growth prospects.”\n\nLiz Ann Sonders, Charles Schwab’s chief investment strategist:\n“Never before has the stock market been valued as much as it is today relative to the size of the total economy; which suggests the stock market has never been more important as an economic driver as it is today.”\n\nMarlena Lee, global head of investment solutions at Dimensional Fund Advisors:\n“This Halloween, beware of investment funds in ‘green’ costumes. Investors searching for portfolios reflecting concerns about climate change may find ESG labels more trick than treat. One in four funds branded as ‘sustainability focused’ show less than 7% reduction in exposure to greenhouse gas (GHG) emissions intensity in comparison to the exposure of the broad market Russell 3000 index. This may be spooky for investors assuming ESG labeling to be a reliable indicator of less exposure to GHG-emitting companies.”\nRoss Mayfield, investment strategy analyst at Baird:\n“Amid the Covid-19 outbreak and subsequent stock market crash, investors piled into money market funds. However, 18 months and one historic rally later, cash on the sidelines remains elevated. Not only is cash earning next to nothing at a time when inflationary pressure is weighing on real returns, but getting back into an equity market near all-time highs is psychologically challenging (particularly one that has presented just a single -5% dip in the last year). It’s scary to think about the double-sided impact this could have on savers and investors long-term.”\n\nWes Crill, head of investment strategists at Dimensional Fund Advisors:\n“Investors expecting momentum strategies to diversify their value exposure may be spooked by the potential overlap between these two. Combining momentum and value strategies may inadvertently double down on one’s value tilt, a scary proposition for those wanting consistent exposure to value. Stocks with high profitability have had a more consistently low overlap with value, the two complementing each other like candy and corn.”","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1521,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863541152,"gmtCreate":1632408078476,"gmtModify":1632731087207,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Niceee","listText":"Niceee","text":"Niceee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/863541152","repostId":"2169664162","repostType":4,"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884076553,"gmtCreate":1631843037872,"gmtModify":1631889028803,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/884076553","repostId":"2168542123","repostType":4,"repost":{"id":"2168542123","kind":"news","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=full","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FANG":"Diamondback Energy","X":"美国钢铁","GRTS":"Gritstone Oncology Inc.","ABCL":"AbCellera Biologics"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1,"symbols_score_info":{"ABCL":0.9,"FANG":0.9,"GRTS":0.9,"X":0.9}},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124967973,"gmtCreate":1624720822592,"gmtModify":1631893538744,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Awesome&nbsp;","listText":"Awesome&nbsp;","text":"Awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/124967973","repostId":"1164137597","repostType":4,"isVote":1,"tweetType":1,"viewCount":325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165888698,"gmtCreate":1624115996514,"gmtModify":1634010565457,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Thanksss!","listText":"Thanksss!","text":"Thanksss!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/165888698","repostId":"1113942445","repostType":4,"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120010161,"gmtCreate":1624287737453,"gmtModify":1634008330730,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Coool","listText":"Coool","text":"Coool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/120010161","repostId":"1154249454","repostType":4,"repost":{"id":"1154249454","kind":"news","pubTimestamp":1624230573,"share":"https://ttm.financial/m/news/1154249454?lang=&edition=full","pubTime":"2021-06-21 07:09","market":"us","language":"en","title":"Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1154249454","media":"barrons","summary":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will r","content":"<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from&nbsp;Johnson &amp;&nbsp;Johnson,&nbsp;GlaxoSmithKline,and&nbsp;Equinix.</p>\n<p>Economic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.</p>\n<p>And on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.</p>\n<p>Monday 6/21</p>\n<p><b>The Federal Reserve Bank</b>of Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.</p>\n<p>Tuesday 6/22</p>\n<p><b>The National Association</b>of Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.</p>\n<p>Wednesday 6/23</p>\n<p>Equinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.</p>\n<p>GlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.</p>\n<p>Johnson &amp; Johnson hosts a webcast to discuss its ESG strategy.</p>\n<p><b>The Census Bureau</b>reports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.</p>\n<p><b>IHS Markitreports</b>both its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.</p>\n<p>Thursday 6/24</p>\n<p><b>The Bureau of Economic Analysis</b>reports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.</p>\n<p>Accenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.</p>\n<p><b>The Bank of England</b>announces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.</p>\n<p><b>The Census Bureau</b>releases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.</p>\n<p>Friday 6/25</p>\n<p>CarMax and Paychex report earnings.</p>\n<p><b>The BEA reports</b>personal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, FedEx, Johnson & Johnson, Darden, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 07:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. ...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FDX":"联邦快递","NKE":"耐克","DRI":"达登饭店","JNJ":"强生"},"source_url":"https://www.barrons.com/articles/nike-fedex-johnson-johnson-darden-and-other-stocks-for-investors-to-watch-this-week-51624215603?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154249454","content_text":"A handful of notable companies will release their latest results toward the end of this week.Nike,FedEx,andDarden Restaurantswill report on Thursday, followed by CarMax and Paychex on Friday. Wednesday will also feature analyst days and investor events from Johnson & Johnson, GlaxoSmithKline,and Equinix.\nEconomic data out this week include IHS’ Manufacturing and Services Purchasing Managers’ Indexes for June on Wednesday. Both are expected to hold near their record highs. The Census Bureau will release the durable-goods report for May on Thursday. Orders—often seen as a decent proxy for business investment—are expected to rise 3.3% month over month.\nAnd on Friday, the Bureau of Economic Analysis will report personal income and consumption for May. Spending is forecast to continue rising despite a drop off in income as stimulus checks finished being sent out in April.\nMonday 6/21\nThe Federal Reserve Bankof Chicago releases its National Activity index, a gauge of overall economic activity, for May. Expectations are for a 0.50 reading, higher than April’s 0.24 figure. A positive reading indicates economic growth that is above historical trends.\nTuesday 6/22\nThe National Associationof Realtors reports existing-home sales for May. Economists forecast a seasonally adjusted annual rate of 5.7 million homes sold, about 150,000 fewer than the April data. Existing-home sales have fallen for three consecutive months, as supply hasn’t been able to keep up with demand.\nWednesday 6/23\nEquinix hosts its 2021 analyst day, when the company will update its long-term financial outlook.\nGlaxoSmithKline hosts a conference call, featuring its CEO, Emma Walmsley, to update investors on the company’s strategy for growth and shareholder value creation.\nJohnson & Johnson hosts a webcast to discuss its ESG strategy.\nThe Census Bureaureports new residential construction data for May. Consensus estimate is for a seasonally adjusted annual rate of 875,000 new single-family homes sold, slightly higher than April’s 863,000. Similar to existing-home sales, new-home sales have fallen from their recent peak of 993,000 in January of this year.\nIHS Markitreportsboth its Manufacturing and Services Purchasing Managers’ indexes for June. Expectations are for a 61.5 reading for the Manufacturing PMI, and a 69.8 figure for the Services PMI. Both projections are comparable to the May data as well as being near record highs for their respective indexes.\nThursday 6/24\nThe Bureau of Economic Analysisreports the third and final estimate of first-quarter gross-domestic-product growth. Economists forecast a seasonally adjusted annual growth rate of 6.4%.\nAccenture,Darden Restaurants, FedEx, and Nike hold conference calls to discuss quarterly results.\nThe Bank of Englandannounces its monetary-policy decision. The central bank is widely expected to keep its key interest rate at 0.1%.\nThe Census Bureaureleases the durable-goods report for May. The consensus call is for new orders of manufactured goods to rise 2.8% month over month to $253 billion. Excluding transportation, new orders are projected at 1%, matching the April data.\nFriday 6/25\nCarMax and Paychex report earnings.\nThe BEA reportspersonal income and consumption for May. Income is expected to fall 3% month over month, after plummeting 13.1% in April. This reflects a dropoff in stimulus checks that first were sent out in March. Spending is seen rising 0.5%, comparable to the April data.","news_type":1,"symbols_score_info":{"DRI":0.9,"FDX":0.9,"JNJ":0.9,"NKE":0.9}},"isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842570716,"gmtCreate":1636208791035,"gmtModify":1636208791623,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842570716","repostId":"2181374735","repostType":4,"repost":{"id":"2181374735","kind":"news","pubTimestamp":1636200960,"share":"https://ttm.financial/m/news/2181374735?lang=&edition=full","pubTime":"2021-11-06 20:16","market":"us","language":"en","title":"Buffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results","url":"https://stock-news.laohu8.com/highlight/detail?id=2181374735","media":"StreetInsider","summary":"(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound fro","content":"<p>(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater loss from insurance underwriting.</p>\n<p>Berkshire also said it repurchased $7.6 billion of its own stock in the third quarter, reflecting its need to put some cash to work as stock prices regularly set new highs and purchases of whole companies appear too expensive.</p>\n<p>Quarterly operating profit rose 18% to $6.47 billion compared with $5.48 billion in the year-earlier period.</p>\n<p>Net income declined 66% to $10.3 billion, or $6,882 per Class A share, from $30.1 billion, reflecting lower unrealized gains on Berkshire's common stock holdings including Apple Inc and $Bank of America Corp(BAC-N)$.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuffett's Berkshire Hathaway boosts operating profit, lower stock gains hurt net results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19172264><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19172264\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19172264","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181374735","content_text":"(Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Saturday it has extended its rebound from the early stages of the pandemic, with improved results in many businesses offsetting a greater loss from insurance underwriting.\nBerkshire also said it repurchased $7.6 billion of its own stock in the third quarter, reflecting its need to put some cash to work as stock prices regularly set new highs and purchases of whole companies appear too expensive.\nQuarterly operating profit rose 18% to $6.47 billion compared with $5.48 billion in the year-earlier period.\nNet income declined 66% to $10.3 billion, or $6,882 per Class A share, from $30.1 billion, reflecting lower unrealized gains on Berkshire's common stock holdings including Apple Inc and $Bank of America Corp(BAC-N)$.","news_type":1,"symbols_score_info":{"BRK.A":0.9,"BRK.B":0.9}},"isVote":1,"tweetType":1,"viewCount":1287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846097695,"gmtCreate":1636034157304,"gmtModify":1636034157902,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846097695","repostId":"1103660582","repostType":4,"repost":{"id":"1103660582","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636032692,"share":"https://ttm.financial/m/news/1103660582?lang=&edition=full","pubTime":"2021-11-04 21:31","market":"us","language":"en","title":"S&P 500 rises for a sixth straight day, Dow hovers near a record","url":"https://stock-news.laohu8.com/highlight/detail?id=1103660582","media":"Tiger Newspress","summary":"The S&P 500 rose for a sixth day in a row on Thursday after the equity benchmark closed at a record ","content":"<p>The S&amp;P 500 rose for a sixth day in a row on Thursday after the equity benchmark closed at a record following commentary from the Federal Reserve in the prior session.</p>\n<p>The S&amp;P 500 gained 0.2%, while the Dow Jones Industrial Average was trading near the flatline. The tech-heavy Nasdaq Composite rose 0.2%. All three averages finished the prior session at record highs.</p>\n<p><img src=\"https://static.tigerbbs.com/2a14d5a66f1a4044fe93913c89576ad8\" tg-width=\"1073\" tg-height=\"456\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla shares rose more than 1% to a new high.</p>\n<p>Qualcomm led gainers on the S&amp;P 500, rallying 15% following&nbsp;an earnings beat&nbsp;propelled by a 56% surge in smartphone chip sales. The company also provide strong guidance for the fourth quarter.</p>\n<p>MGM shares gained nearly 5% after the casino operator announcing plans to sell the operations of its Mirage casino in Las Vegas to another operator. The company noted that no sales agreement had been reached and it did not mention any possible buyers.</p>\n<p>Fastly's stock rose 8%&nbsp;as&nbsp;its third quarter performance exceeded market expectations, and some lost users were observed to return.</p>\n<p>Yet Moderna shares cratered after the drugmaker&nbsp;slashed its Covid-19 vaccine revenue outlook. The sotck was last down about 11%.</p>\n<p>And Roku was under pressure, falling more than 7% after the streaming platform&nbsp;reported disappointing third-quarter revenue.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 rises for a sixth straight day, Dow hovers near a record</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 rises for a sixth straight day, Dow hovers near a record\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-04 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The S&amp;P 500 rose for a sixth day in a row on Thursday after the equity benchmark closed at a record following commentary from the Federal Reserve in the prior session.</p>\n<p>The S&amp;P 500 gained 0.2%, while the Dow Jones Industrial Average was trading near the flatline. The tech-heavy Nasdaq Composite rose 0.2%. All three averages finished the prior session at record highs.</p>\n<p><img src=\"https://static.tigerbbs.com/2a14d5a66f1a4044fe93913c89576ad8\" tg-width=\"1073\" tg-height=\"456\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla shares rose more than 1% to a new high.</p>\n<p>Qualcomm led gainers on the S&amp;P 500, rallying 15% following&nbsp;an earnings beat&nbsp;propelled by a 56% surge in smartphone chip sales. The company also provide strong guidance for the fourth quarter.</p>\n<p>MGM shares gained nearly 5% after the casino operator announcing plans to sell the operations of its Mirage casino in Las Vegas to another operator. The company noted that no sales agreement had been reached and it did not mention any possible buyers.</p>\n<p>Fastly's stock rose 8%&nbsp;as&nbsp;its third quarter performance exceeded market expectations, and some lost users were observed to return.</p>\n<p>Yet Moderna shares cratered after the drugmaker&nbsp;slashed its Covid-19 vaccine revenue outlook. The sotck was last down about 11%.</p>\n<p>And Roku was under pressure, falling more than 7% after the streaming platform&nbsp;reported disappointing third-quarter revenue.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103660582","content_text":"The S&P 500 rose for a sixth day in a row on Thursday after the equity benchmark closed at a record following commentary from the Federal Reserve in the prior session.\nThe S&P 500 gained 0.2%, while the Dow Jones Industrial Average was trading near the flatline. The tech-heavy Nasdaq Composite rose 0.2%. All three averages finished the prior session at record highs.\n\nTesla shares rose more than 1% to a new high.\nQualcomm led gainers on the S&P 500, rallying 15% following an earnings beat propelled by a 56% surge in smartphone chip sales. The company also provide strong guidance for the fourth quarter.\nMGM shares gained nearly 5% after the casino operator announcing plans to sell the operations of its Mirage casino in Las Vegas to another operator. The company noted that no sales agreement had been reached and it did not mention any possible buyers.\nFastly's stock rose 8% as its third quarter performance exceeded market expectations, and some lost users were observed to return.\nYet Moderna shares cratered after the drugmaker slashed its Covid-19 vaccine revenue outlook. The sotck was last down about 11%.\nAnd Roku was under pressure, falling more than 7% after the streaming platform reported disappointing third-quarter revenue.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854824179,"gmtCreate":1635434618523,"gmtModify":1635434619054,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854824179","repostId":"1173352835","repostType":4,"isVote":1,"tweetType":1,"viewCount":1630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859761016,"gmtCreate":1634736548790,"gmtModify":1634736552632,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859761016","repostId":"1139065544","repostType":4,"repost":{"id":"1139065544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634731709,"share":"https://ttm.financial/m/news/1139065544?lang=&edition=full","pubTime":"2021-10-20 20:08","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1139065544","media":"Tiger Newspress","summary":"US index futures were little changed as investors weighed the start of the earnings season against g","content":"<p>US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy</p>\n<p>crisis.&nbsp;</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&amp;P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.<img src=\"https://static.tigerbbs.com/69fa6d32c1b1d5935b3f4750ce19cd71\" tg-width=\"287\" tg-height=\"117\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>United Airlines (UAL US) gains 2% in U.S.&nbsp;premarket&nbsp;trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September</li>\n <li>Novavax (NVAX US) shares fall as much as 25% in U.S.&nbsp;premarket&nbsp;trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels</li>\n <li>Vinco Ventures (BBIG US) shares slump 15% in&nbsp;premarket&nbsp;trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman</li>\n <li>Ford (F US) shares gain 1.7%&nbsp;premarket&nbsp;after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year</li>\n <li>Stride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate</li>\n <li>WD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate</li>\n <li>Omnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates</li>\n <li>Canadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate</li>\n <li>Akero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S</li>\n</ul>\n<p>In rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,</p>\n<p>where short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength.&nbsp;</p>\n<p>In commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.</p>\n<p>In cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-20 20:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy</p>\n<p>crisis.&nbsp;</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&amp;P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.<img src=\"https://static.tigerbbs.com/69fa6d32c1b1d5935b3f4750ce19cd71\" tg-width=\"287\" tg-height=\"117\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>United Airlines (UAL US) gains 2% in U.S.&nbsp;premarket&nbsp;trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September</li>\n <li>Novavax (NVAX US) shares fall as much as 25% in U.S.&nbsp;premarket&nbsp;trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels</li>\n <li>Vinco Ventures (BBIG US) shares slump 15% in&nbsp;premarket&nbsp;trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman</li>\n <li>Ford (F US) shares gain 1.7%&nbsp;premarket&nbsp;after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year</li>\n <li>Stride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate</li>\n <li>WD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate</li>\n <li>Omnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates</li>\n <li>Canadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate</li>\n <li>Akero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S</li>\n</ul>\n<p>In rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,</p>\n<p>where short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength.&nbsp;</p>\n<p>In commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.</p>\n<p>In cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UAL":"联合大陆航空","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139065544","content_text":"US index futures were little changed as investors weighed the start of the earnings season against growing stagflation, tightening, energy\ncrisis. \nAt 8:00 a.m. ET, Dow e-minis were down 25 points, or 0.07%, S&P 500 e-minis were down 3.5 points, or 0.08%, and Nasdaq 100 e-minis were down 5.5 points, or 0.04%.\n\nUnited Airlines (UAL US) gains 2% in U.S. premarket trading after the airline posted a narrower loss than expected despite the impact of the coronavirus delta variant. Cowen notes that 3Q was better than expected and also ahead of management’s last guidance from early September\nNovavax (NVAX US) shares fall as much as 25% in U.S. premarket trading after Politico reported a potential delay in registering its Covid-19 vaccine candidate with the U.S. Food and Drug Administration in connection with inadequate purity levels\nVinco Ventures (BBIG US) shares slump 15% in premarket trading after the company reported the resignations of Chief Executive Officer Christopher Ferguson and Chief Financial Officer Brett Vroman\nFord (F US) shares gain 1.7% premarket after Credit Suisse upgrades to outperform with joint Street-high target of $20 following a significant turnaround over the past year\nStride (LRN US) gained 7.9% Tuesday postmarket after the education company forecast revenue for the full year that beat the highest analyst estimate\nWD-40 (WDFC US) sank 10% in postmarket trading after forecasting earnings per share for 2022 that missed the average analyst estimate\nOmnicom (OMC US) fell 3% in postmarket trading after third quarter revenue fell short of some analyst estimates\nCanadian National (CNI US) U.S.-listed shares rose 4.6% in postmarket trading after reporting adjusted earnings per share for the third quarter that beat the average analyst estimate\nAkero Therapeutics (AKRO US) shares rose as much as 12% in Tuesday extended trading after co. said the U.S\n\nIn rates, treasuries were narrowly mixed and off lows reached during Asia session after being led higher during European morning by gilts,\nwhere short maturities outperform. The 10-year TSY yield touched 1.67%, the highest level since May. The treasury futures rally stalled after a block sale in 10-year contracts, apparently fading strength. \nIn commodities, crude futures drift lower. WTI drops 0.9% near $82.20, Brent is 1% lower holding above $84. Spot gold slowly extends Asia’s gains, rising $9 to trade near $1,780/oz. Most base metals are under pressure with LME copper and aluminum underperforming peers.\nIn cryptocurrencies, bitcoin stood at $64,068, near its all-time peak of $64,895 as the first U.S. bitcoin futures-based exchange-traded fund began trading on Tuesday.","news_type":1,"symbols_score_info":{"NVAX":0.9,"UAL":0.9}},"isVote":1,"tweetType":1,"viewCount":1207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823664948,"gmtCreate":1633618943184,"gmtModify":1633618943793,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823664948","repostId":"2173497159","repostType":4,"repost":{"id":"2173497159","kind":"highlight","pubTimestamp":1633606500,"share":"https://ttm.financial/m/news/2173497159?lang=&edition=full","pubTime":"2021-10-07 19:35","market":"us","language":"en","title":"Charlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173497159","media":"Motley Fool","summary":"Charlie Munger was greedy when others were fearful over China and Alibaba this summer.","content":"<p>In a recent regulatory filing, <b>The <a href=\"https://laohu8.com/S/DJCO\">Daily Journal</a></b> disclosed that it had bought more shares of Chinese giant <b><a href=\"https://laohu8.com/S/BABA\">Alibaba</a></b> with its corporate cash. The decision was probably the work of Charlie Munger, Warren Buffett's partner and <b><a href=\"https://laohu8.com/S/BRK.A\">Berkshire Hathaway</a></b> vice chairman. Munger is also the chairman of The Daily Journal and holds 3.6% of the company's shares.</p>\n<p>Although The Daily Journal started off as a legal newspaper and is now transitioning to become a software company to local court systems, it uses its cash holdings to invest in equities, which make up a significant portion of the company's market cap.</p>\n<p>While The Daily Journal's concentrated portfolio consists mainly of large U.S. banks, in the first quarter, Munger, a longtime <a href=\"https://laohu8.com/S/CAAS\">China</a> bull, bought a stake in <a href=\"https://laohu8.com/S/09988\">Alibaba</a>. With that investment having gone south this summer, The Daily Journal's recent disclosure shows Munger nearly doubling down on his bet as Alibaba's share price plummeted.</p>\n<p><img src=\"https://static.tigerbbs.com/1b1161f51c34685fdb339ca2519e8fbc\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>Still believing in BABA</h3>\n<p>In the filing, The Daily Journal disclosed that its stake in Alibaba had risen from 165,320 shares at the end of the first quarter to 302,060 shares at the end of Q3. That's an 83% increase -- a near doubling of Munger's bet. The company's stake in Alibaba now totals about $45 million -- good for about 20% of the Daily Journal's portfolio.</p>\n<p>It has been a rough year for Alibaba's stock, as shares are down 38.5% on the year and a whopping 56.3% from all-time highs set back in 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/fc3631e8a8bdb0723f45707ca1878a64\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>BABA data by YCharts</p>\n<p>As Munger is a noted value investor, if he believed Alibaba was a cheap stock back in April, when shares where in the $230-$240 per share range, he probably loves it now, with the stock currently trading in the $140s. It's a prime example of adhering to partner Warren Buffett's famous quote: \"Be fearful when others are greedy, and greedy when others are fearful.\"</p>\n<h3>But should you follow Munger into Alibaba?</h3>\n<p>If you're investing your own money, as a general rule, it's usually best not to blindly follow others into an investment, even if they're famous investors. Famous investors can make mistakes, too, and if a trade goes south and you don't know <i>why</i> you own something, you may panic and sell at the wrong time.</p>\n<p>Alibaba is a fascinating case, of course, as there are plenty of valid reasons for an investor to be both bullish or bearish at this time of great uncertainty.</p>\n<p><img src=\"https://static.tigerbbs.com/f41181175cea4ae5ef058c33c860564a\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The bull case on BABA: It looks very cheap</h3>\n<p>On the bullish side, Alibaba is of course a leading player in Chinese e-commerce, payments and fintech, and the cloud. With an entrenched position in these three high-growth areas, and given that Munger is known to be bullish on the long-term growth prospects of China and its rising middle class, it seems a pretty safe bet that Alibaba should grow in the years ahead.</p>\n<p>So when the IPO of Alibaba subsidiary Ant Financial was stopped a year ago and its stock fell, Munger swooped in, buying shares when Alibaba's P/E ratio fell to the high 20s. However, Alibaba also had about $135 billion in net cash and other investments in other companies at that time, so the \"core\" business was actually much cheaper than that. And Alibaba also has several promising but loss-making subsidiaries, such as its cloud computing platform, which probably has significant positive value but contributes negatively to current earnings.</p>\n<p>Over the summer, Alibaba's valuation has fallen all the way to just 17.3 times trailing earnings. That's <i>extremely</i> cheap, especially considering, again, Alibaba's prodigious cash holdings and investments, as well as several loss-making business segments. And even with all the negativity in Alibaba's stock today, analysts still estimate future growth, albeit more muted. Based on 2023 estimates, Alibaba trades at only 13.3 times earnings.</p>\n<h3>Reasons to be bearish: slowing growth and increased regulations</h3>\n<p>However, Munger may have misjudged the extent that Alibaba and other Chinese tech companies were to be punished. After a $2.8 billion fine for violating antimonopoly rules in e-commerce back in April, regulators have continued to issue regulations on delivery worker pay as well as restrictions on data collection, which could broadly affect Alibaba's portfolio of businesses.</p>\n<p>Ant Financial may be broken up into three separate businesses, effectively knocking down the company's moat against rivals. Even on the core business, recent regulations could open Alibaba's main cash cow e-commerce business to more fierce competition.</p>\n<p>In August, its earnings report for the quarter ending in June revealed that it was light on revenue, disappointing some investors. While headline revenue grew 34%, outside of a large acquisition, revenue grew just 22% -- still a solid figure, but a deceleration from Alibaba's past rate. Recent troubles at <b>Evergrande</b> (OTC:EGRN.F), the large Chinese real estate developer, may still spill over into the broader Chinese economy. That could affect the Chinese consumer, which means less buying and lower revenue for Alibaba.</p>\n<p>Finally, Alibaba also recently announced a $15.5 billion \"social equity\" fund to tackle societal challenges such as gig-worker welfare, rural area development, and the growth of small and medium-sized businesses. That fund doesn't necessarily have a financial payoff.</p>\n<p>Finally, U.S.-China relations have been frosty to say the least, and further tensions could cause China to take unilateral actions against foreign shareholders of domestic companies. Alibaba is listed in the U.S., but because of Chinese rules, non-Chinese shareholders don't directly own shares, but rather shares of a variable interest entity (VIE) listed in the Cayman Islands, which has a contractual right to part of Alibaba's business. Should things go south between the two countries, it's possible -- a long shot, but still possible -- that China may look to take aim at the VIE structure and contracts.</p>\n<h3>Factor these things in when looking to buy Alibaba</h3>\n<p>Munger has long been positive on the growth of China, and it's safe to say he knows an awful lot about the country. However, there are also other smart people with a more pessimistic view of China.</p>\n<p>In buying Alibaba, investors need to have confidence the current regulatory campaign will eventually stop or moderate, and that Alibaba will still be able to function as a relatively normal profit-making company -- albeit with more regulations. Obviously, Munger believes that will happen after this period of turbulence, but it's by no means a sure thing.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharlie Munger Just Doubled Down on Alibaba: Should Investors Follow Suit?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 19:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In a recent regulatory filing, The Daily Journal disclosed that it had bought more shares of Chinese giant Alibaba with its corporate cash. The decision was probably the work of Charlie Munger, Warren...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISBC":"投资者银行","BABA":"阿里巴巴","DJCO":"每日期刊"},"source_url":"https://www.fool.com/investing/2021/10/07/charlie-munger-just-doubled-down-on-alibaba/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173497159","content_text":"In a recent regulatory filing, The Daily Journal disclosed that it had bought more shares of Chinese giant Alibaba with its corporate cash. The decision was probably the work of Charlie Munger, Warren Buffett's partner and Berkshire Hathaway vice chairman. Munger is also the chairman of The Daily Journal and holds 3.6% of the company's shares.\nAlthough The Daily Journal started off as a legal newspaper and is now transitioning to become a software company to local court systems, it uses its cash holdings to invest in equities, which make up a significant portion of the company's market cap.\nWhile The Daily Journal's concentrated portfolio consists mainly of large U.S. banks, in the first quarter, Munger, a longtime China bull, bought a stake in Alibaba. With that investment having gone south this summer, The Daily Journal's recent disclosure shows Munger nearly doubling down on his bet as Alibaba's share price plummeted.\n\nImage source: Getty Images.\nStill believing in BABA\nIn the filing, The Daily Journal disclosed that its stake in Alibaba had risen from 165,320 shares at the end of the first quarter to 302,060 shares at the end of Q3. That's an 83% increase -- a near doubling of Munger's bet. The company's stake in Alibaba now totals about $45 million -- good for about 20% of the Daily Journal's portfolio.\nIt has been a rough year for Alibaba's stock, as shares are down 38.5% on the year and a whopping 56.3% from all-time highs set back in 2020.\n\nBABA data by YCharts\nAs Munger is a noted value investor, if he believed Alibaba was a cheap stock back in April, when shares where in the $230-$240 per share range, he probably loves it now, with the stock currently trading in the $140s. It's a prime example of adhering to partner Warren Buffett's famous quote: \"Be fearful when others are greedy, and greedy when others are fearful.\"\nBut should you follow Munger into Alibaba?\nIf you're investing your own money, as a general rule, it's usually best not to blindly follow others into an investment, even if they're famous investors. Famous investors can make mistakes, too, and if a trade goes south and you don't know why you own something, you may panic and sell at the wrong time.\nAlibaba is a fascinating case, of course, as there are plenty of valid reasons for an investor to be both bullish or bearish at this time of great uncertainty.\n\nImage source: Getty Images.\nThe bull case on BABA: It looks very cheap\nOn the bullish side, Alibaba is of course a leading player in Chinese e-commerce, payments and fintech, and the cloud. With an entrenched position in these three high-growth areas, and given that Munger is known to be bullish on the long-term growth prospects of China and its rising middle class, it seems a pretty safe bet that Alibaba should grow in the years ahead.\nSo when the IPO of Alibaba subsidiary Ant Financial was stopped a year ago and its stock fell, Munger swooped in, buying shares when Alibaba's P/E ratio fell to the high 20s. However, Alibaba also had about $135 billion in net cash and other investments in other companies at that time, so the \"core\" business was actually much cheaper than that. And Alibaba also has several promising but loss-making subsidiaries, such as its cloud computing platform, which probably has significant positive value but contributes negatively to current earnings.\nOver the summer, Alibaba's valuation has fallen all the way to just 17.3 times trailing earnings. That's extremely cheap, especially considering, again, Alibaba's prodigious cash holdings and investments, as well as several loss-making business segments. And even with all the negativity in Alibaba's stock today, analysts still estimate future growth, albeit more muted. Based on 2023 estimates, Alibaba trades at only 13.3 times earnings.\nReasons to be bearish: slowing growth and increased regulations\nHowever, Munger may have misjudged the extent that Alibaba and other Chinese tech companies were to be punished. After a $2.8 billion fine for violating antimonopoly rules in e-commerce back in April, regulators have continued to issue regulations on delivery worker pay as well as restrictions on data collection, which could broadly affect Alibaba's portfolio of businesses.\nAnt Financial may be broken up into three separate businesses, effectively knocking down the company's moat against rivals. Even on the core business, recent regulations could open Alibaba's main cash cow e-commerce business to more fierce competition.\nIn August, its earnings report for the quarter ending in June revealed that it was light on revenue, disappointing some investors. While headline revenue grew 34%, outside of a large acquisition, revenue grew just 22% -- still a solid figure, but a deceleration from Alibaba's past rate. Recent troubles at Evergrande (OTC:EGRN.F), the large Chinese real estate developer, may still spill over into the broader Chinese economy. That could affect the Chinese consumer, which means less buying and lower revenue for Alibaba.\nFinally, Alibaba also recently announced a $15.5 billion \"social equity\" fund to tackle societal challenges such as gig-worker welfare, rural area development, and the growth of small and medium-sized businesses. That fund doesn't necessarily have a financial payoff.\nFinally, U.S.-China relations have been frosty to say the least, and further tensions could cause China to take unilateral actions against foreign shareholders of domestic companies. Alibaba is listed in the U.S., but because of Chinese rules, non-Chinese shareholders don't directly own shares, but rather shares of a variable interest entity (VIE) listed in the Cayman Islands, which has a contractual right to part of Alibaba's business. Should things go south between the two countries, it's possible -- a long shot, but still possible -- that China may look to take aim at the VIE structure and contracts.\nFactor these things in when looking to buy Alibaba\nMunger has long been positive on the growth of China, and it's safe to say he knows an awful lot about the country. However, there are also other smart people with a more pessimistic view of China.\nIn buying Alibaba, investors need to have confidence the current regulatory campaign will eventually stop or moderate, and that Alibaba will still be able to function as a relatively normal profit-making company -- albeit with more regulations. Obviously, Munger believes that will happen after this period of turbulence, but it's by no means a sure thing.","news_type":1,"symbols_score_info":{"BABA":0.9,"DJCO":0.9,"ISBC":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865732815,"gmtCreate":1633017160194,"gmtModify":1633017160599,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865732815","repostId":"1164073079","repostType":4,"repost":{"id":"1164073079","kind":"news","pubTimestamp":1632985852,"share":"https://ttm.financial/m/news/1164073079?lang=&edition=full","pubTime":"2021-09-30 15:10","market":"us","language":"en","title":"Cathie Wood’s ARK Invest Sold Tesla Stock. Bulls Shouldn’t Worry.","url":"https://stock-news.laohu8.com/highlight/detail?id=1164073079","media":"Barrons","summary":"Disruption-stock guru Cathie Wood has become an important voice for bullish Tesla investors, so when her ETF, ARK Innovation, buys or sells the shares, it is news. The risk for investors is overreacting.Closely following what is going in a favorite stock is a good idea. Responding to all the daily data points is less so.Wood’s ARK Innovation ETF  sold more than $200 million in Tesla stock in recent days, based on data compiled from Bloomberg.Big sales are potentially alarming for bulls, but ARK’","content":"<p>Disruption-stock guru Cathie Wood has become an important voice for bullish Tesla investors, so when her ETF, ARK Innovation, buys or sells the shares, it is news. The risk for investors is overreacting.</p>\n<p>Closely following what is going in a favorite stock is a good idea. Responding to all the daily data points is less so.</p>\n<p>Wood’s&nbsp;ARK Innovation ETF&nbsp;(ticker: ARKK) sold more than $200 million in Tesla stock in recent days, based on data compiled from Bloomberg.</p>\n<p>Big sales are potentially alarming for bulls, but ARK’s recent moves are most likely typical portfolio-management activity. Institutional investors often have internally imposed limits on the size of the positions they hold. And ETFs have daily inflows and outflows of investment dollars they have to manage.</p>\n<p>ARK didn’t immediately respond to a request for comment about the recent sales, but the ETF still has a lot riding on how Tesla does. Tesla stock remains the largest holding in the ETF by a factor of almost two.</p>\n<p>The stock has also outperforming other components of the ETF over the past few weeks. The stock accounts for an increasingly large percentage of the ARK Innovation portfolio just because of that fact alone.</p>\n<p>Tesla shares have gained about 9% over the past month. The next 10 largest positions, including&nbsp;Teladoc Health&nbsp;(TDOC),Roku&nbsp;(ROKU),Unity Software&nbsp;(U),Coinbase&nbsp;(COIN),Zoom Video Communications&nbsp;(ZM),Square (SQ),Shopify&nbsp;(SHOP),Spotify Technology&nbsp;(SPOT),Twilio&nbsp;(TWLO) and&nbsp;Palantir Technologies&nbsp;(PLTR), are down about 10% on average over the same span.</p>\n<p>It’s a large drop for the other 10 stocks, but not a surprising one. Growth stocks such as the ones Wood’s fund holds are expected to generate most of their earnings and cash flow years from now, and higher interest rates, such as those seen recently, tend to reduce the current value of future earnings. The yield on 10-year U.S. Treasury debt has gone from 1.45% to 1.54% this week.</p>\n<p>Tesla, also a growth company, has managed to buck that trend because of factors specific to it. Investors have felt more optimistic about the stock since the company launched more sophisticated versions of its autonomous-driving software this past Friday, and as delivery estimates for the third quarter have inched higher.</p>\n<p>Wall Street is expecting roughly 225,000 vehicle deliveries for the third quarter of 2021, up from closer to 221,000 deliveries a few weeks back.</p>\n<p>Tesla stock is up about 0.3% for the week. The&nbsp;Nasdaq Composite,home to many richly valued tech stocks such as Tesla, has lost more than 3%. Near midday on Wednesday, Tesla stock was down about 0.3%, while the&nbsp;S&amp;P 500&nbsp;and&nbsp;Dow Jones Industrial Average&nbsp;had both gained roughly 0.3%.</p>\n<p>Tuesday, when the Nasdaq dropped 2.8%, Tesla shares lost only 1.7%.</p>\n<p>It is possible that Wood is feeling differently about Tesla stock these days. But her published target for the share price is $3,000 by 2025, implying an average annual gain of roughly 40% for the next few years, from near $780 today.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood’s ARK Invest Sold Tesla Stock. Bulls Shouldn’t Worry.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood’s ARK Invest Sold Tesla Stock. Bulls Shouldn’t Worry.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 15:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-cathie-woods-ark-invest-51632942030?mod=hp_DAY_Theme_1_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Disruption-stock guru Cathie Wood has become an important voice for bullish Tesla investors, so when her ETF, ARK Innovation, buys or sells the shares, it is news. The risk for investors is ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-cathie-woods-ark-invest-51632942030?mod=hp_DAY_Theme_1_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","ARKW":"ARK Next Generation Internet ETF","ARKG":"ARK Genomic Revolution ETF","TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-cathie-woods-ark-invest-51632942030?mod=hp_DAY_Theme_1_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164073079","content_text":"Disruption-stock guru Cathie Wood has become an important voice for bullish Tesla investors, so when her ETF, ARK Innovation, buys or sells the shares, it is news. The risk for investors is overreacting.\nClosely following what is going in a favorite stock is a good idea. Responding to all the daily data points is less so.\nWood’s ARK Innovation ETF (ticker: ARKK) sold more than $200 million in Tesla stock in recent days, based on data compiled from Bloomberg.\nBig sales are potentially alarming for bulls, but ARK’s recent moves are most likely typical portfolio-management activity. Institutional investors often have internally imposed limits on the size of the positions they hold. And ETFs have daily inflows and outflows of investment dollars they have to manage.\nARK didn’t immediately respond to a request for comment about the recent sales, but the ETF still has a lot riding on how Tesla does. Tesla stock remains the largest holding in the ETF by a factor of almost two.\nThe stock has also outperforming other components of the ETF over the past few weeks. The stock accounts for an increasingly large percentage of the ARK Innovation portfolio just because of that fact alone.\nTesla shares have gained about 9% over the past month. The next 10 largest positions, including Teladoc Health (TDOC),Roku (ROKU),Unity Software (U),Coinbase (COIN),Zoom Video Communications (ZM),Square (SQ),Shopify (SHOP),Spotify Technology (SPOT),Twilio (TWLO) and Palantir Technologies (PLTR), are down about 10% on average over the same span.\nIt’s a large drop for the other 10 stocks, but not a surprising one. Growth stocks such as the ones Wood’s fund holds are expected to generate most of their earnings and cash flow years from now, and higher interest rates, such as those seen recently, tend to reduce the current value of future earnings. The yield on 10-year U.S. Treasury debt has gone from 1.45% to 1.54% this week.\nTesla, also a growth company, has managed to buck that trend because of factors specific to it. Investors have felt more optimistic about the stock since the company launched more sophisticated versions of its autonomous-driving software this past Friday, and as delivery estimates for the third quarter have inched higher.\nWall Street is expecting roughly 225,000 vehicle deliveries for the third quarter of 2021, up from closer to 221,000 deliveries a few weeks back.\nTesla stock is up about 0.3% for the week. The Nasdaq Composite,home to many richly valued tech stocks such as Tesla, has lost more than 3%. Near midday on Wednesday, Tesla stock was down about 0.3%, while the S&P 500 and Dow Jones Industrial Average had both gained roughly 0.3%.\nTuesday, when the Nasdaq dropped 2.8%, Tesla shares lost only 1.7%.\nIt is possible that Wood is feeling differently about Tesla stock these days. But her published target for the share price is $3,000 by 2025, implying an average annual gain of roughly 40% for the next few years, from near $780 today.","news_type":1,"symbols_score_info":{"ARKG":0.9,"ARKK":0.9,"ARKW":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":158510162,"gmtCreate":1625155037156,"gmtModify":1631893538739,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/158510162","repostId":"1113357649","repostType":2,"repost":{"id":"1113357649","kind":"news","pubTimestamp":1625133776,"share":"https://ttm.financial/m/news/1113357649?lang=&edition=full","pubTime":"2021-07-01 18:02","market":"us","language":"en","title":"Amazon: Undervalued With Potential Upside Of 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113357649","media":"seekingalpha","summary":"Amazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters.I initiate Amazon with a bullish rating and a fair value of $3576/share .The company's improving top line and bottom line performance  suggests that the stock is currently undervalued by 3.9%.Amazon, a $1.74 trillion company. This is the current market capitalization  of the company and this implies that it is currently 15.18% away from being a $2 trillion company, not bad no?I initiate","content":"<p><b>Summary</b></p>\n<ul>\n <li>Amazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters.</li>\n <li>I initiate Amazon with a bullish rating and a fair value of $3576/share (vs. the current price of $3443/share).</li>\n <li>The company's improving top line and bottom line performance (which is expected to continue) suggests that the stock is currently undervalued by 3.9%.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/51ce52baed5afae04a384059297465d3\" tg-width=\"1536\" tg-height=\"1024\"><span>Daria Nipot/iStock Editorial via Getty Images</span></p>\n<p><b>Company Overview</b></p>\n<p>Amazon(NASDAQ:AMZN), a $1.74 trillion company. This is the current market capitalization (as of 06/29/2021) of the company and this implies that it is currently 15.18% away from being a $2 trillion company, not bad no?</p>\n<p>Amazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters. For example, when Amazon announced the acquisition of Whole Foods, Walmart(NYSE:WMT), Kroger(NYSE:KR), Target(NYSE:TGT)took a&nbsp;nice hit&nbsp;in market value. I believe that the company will be able to keep delivering strong top line growth and continued growth in margins, fueled not only by the company's current business expansion but also by entering into new markets and new businesses.</p>\n<p><b>Company Analysis</b></p>\n<p>I initiate Amazon with a bullish rating and a fair value of $3576/share (vs. the current price of $3443/share). The FV is an algorithm-adjusted fair value (the algorithm takes into account fundamental and technical factors, such as DCF FV, momentum, etc.) and it implies that the stock is undervalued by 3.9%.</p>\n<p>To compute the DCF FV, I used the trailing twelve-month numbers and I also restated the financials since I capitalized on R&amp;D expenses with an amortizable life of 3 years. As&nbsp;with Apple(NASDAQ:AAPL), I don't believe that Amazon's R&amp;D is an operating expense, and for this reason, I treat it as CapEx. By taking into account the R&amp;D, the following metrics have been restated (all numbers in $mm).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bb427d462596db1e1cb1ffc99acc90e4\" tg-width=\"571\" tg-height=\"240\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>Capitalizing on R&amp;D expenses, we have now a more clear picture of the company (i.e. the restated operating margin is now 9.03% TTM vs the non-restated operating margin is 6.63% TTM).</p>\n<p><b>Discounted Cash Flow Model</b></p>\n<p>Now, let's turn to the discounted cash flow valuation part. Below, you can see the results with the relative assumptions I have made.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0e215b21ca0b3be5a5e0e7b62e36fb5f\" tg-width=\"640\" tg-height=\"268\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>In my DCF model, I assume a revenue growth for the Y1 of 21.2%, a CAGR Y2-Y5 of 15% and I assume a terminal year growth rate of 1.48% (or the current yield on 10Y Treasury). The decision of using the current and not expected yield is due to the willingness to remain market neutral (perhaps you can use&nbsp;Goldman Sachs expectations&nbsp;of 1.9%). The current assumptions lead to revenues of $1,253,844 million in Y10.</p>\n<p>Along the road, I also assume an improving outlook for operating margins with the target operating margin of 13.2% (vs current restated operating margin of 9.03%). If the company will be able to meet this target, it will result in operating margins in Y10 of $163,097 million.</p>\n<p>Finally, in doing my estimates, I used a WACC of 5.75% and a sales to capital ratio (or how much the company is going to reinvest to keep its business growing) of 2.95.</p>\n<p>By putting it together, I obtain a DCF value of $3328/share.</p>\n<p><b>Monte Carlo Simulation</b></p>\n<p>Rather than showing you only my point estimates, which may be right but also may be wrong, let's use probability distributions for inputs. Simulations allow us to assess the impact of continuous risk (e.g., changes in operating margins). In particular, I would like to focus on what I consider the main inputs of interest to get a bigger picture of the risk in the company. Those inputs are:</p>\n<p><i>1. Revenue Growth:</i></p>\n<p>In my DCF analysis, I assumed an expected CAGR Y2-Y5 of 15% with lower rates going forward. This assumption lead to revenues in Y10 of $1,253,844 million. While it is a reasonable assumption, Amazon is full of surprises, and it may deliver a top line growth well above my expectations. In the latter, I see a possible scenario with a CAGR Y2-Y5 of 24%, resulting in Y10 revenues of $1,989,952 million. However, we all know that regulators represent a big risk for the company. According to&nbsp;WSJ sources, if the \"giant-tech bill\" will pass, the company may be forced to either split into two companies or spin off its private-label product businesses. This represents a big risk that may slow down Amazon's growth, which could translate into a growth rate of 6% (resulting in Y10 revenues of $764,723 million). To sum up, I will assume a uniform distribution with a maximum of 24% and a minimum of 6%. The results are displayed below (this simulation and the next one have been performed 10,000 times).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/893dff753c8ca210759feb31b3966a5c\" tg-width=\"640\" tg-height=\"235\"><span>Source:Author's estimates</span></p>\n<p><i>2. Operating Margin</i>:</p>\n<p>Currently, Amazon has a restated operating margin of 9.03% TTM (vs not restated EBIT margin of 6.83%). In my DCF, I assumed a target operating margin of 13.2%. While this represents my most likely scenario for the company, I cannot close my eyes to the fact that, even if the company is improving its margins, it is following a very slow climb. Below, I display the non-restated EBIT margin for the last 5 years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6d66fcb05f4254b15de278f016121ffa\" tg-width=\"640\" tg-height=\"221\"><span>Source:SeekingAlpha.com</span></p>\n<p>However, as I stated at the beginning, Amazon is a disruptive company with the ability to do extraordinary things. For instance, AWS presents a current operating margin of 30% TTM and a revenue growth rate of 29.53% in 2020. A trend which is expected to continue, driven by improving outlook and with new partners joining the party. The last to join the party are Ferrari(NYSE:RACE)and Swisscom(OTCPK:SWZCF)who have chosen AWS as their&nbsp;preferred cloud partner.</p>\n<p>In 2020,according to Gartner, AWS generated revenue 2 times bigger than Microsoft(NASDAQ:MSFT). As stated by Gartner:</p>\n<blockquote>\n <i>The worldwide</i>&nbsp;\n <i>infrastructure as a service(IaaS) market grew 40.7% in 2020 to total $64.3 billion, up from $45.7 billion in 2019, according to Gartner, Inc. Amazon retained the No. 1 position in the IaaS market in 2020, followed by Microsoft, Alibaba, Google and Huawei... Amazon continued to lead the worldwide IaaS market with $26.2 billion of revenue in 2020 and 41% market share.</i>\n</blockquote>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac00a17cbbd930ad6464a63f6d4f98eb\" tg-width=\"640\" tg-height=\"388\"><span>Source:Gartner.com</span></p>\n<p>Finally, to account for my concerns and beliefs, I will assume a triangular distribution with the following limits: the likeliest target operating margin of 13.2%, a maximum of 18.4%, and a minimum of 8% (close to the current company's EBIT margin). The results are displayed below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/054e2db392be500768de741516186013\" tg-width=\"640\" tg-height=\"237\"><span>Source:Author's estimates</span></p>\n<p><i>3. Cost of Capital:</i></p>\n<p>The last input of interest is the cost of capital. In doing my analysis, I estimated a cost of capital of 5.8% (with the current 10Y rate of 1.48 and an implied ERP of 4.54%). However, I may be wrong due to sector risk estimates or changes in the business mix (or both). To account for the possibility that I made some mistakes along the road, I will rely on a lognormal distribution with the most likely scenario of 5.8%. The results of the simulation are displayed below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a7d51740fa35eb9aedbc58c4c49d96eb\" tg-width=\"640\" tg-height=\"235\"><span>Source:Author's estimates</span></p>\n<p>By putting all of this together, the simulations return the following results.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/139c89300706eab1e37dd1c992286d31\" tg-width=\"640\" tg-height=\"222\"><span>Source:Author's estimates</span></p>\n<p>For completeness, I also display below the relative and cumulative frequency of the simulation.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/af7a908e21b8678a775a3e1742161a7d\" tg-width=\"573\" tg-height=\"644\"><span>Source:Author's estimates</span></p>\n<p>By looking at the results, we can see that the 50th percentile or the median is equal to $3274, close to the expected DCF FV of $3328. While the algorithm-adjusted FV of $3576 is the 60th percentile in my simulations (note also the long right tail).</p>\n<p>Finally, simulation results give us an interesting insight into a potential exit point. I believe that an interesting take profit point may be within the 80th percentile, which implies a potential upside of 24.89%. Why within the 80th percentile? I believe that, after reaching the $2.0 trillion company status, we will see the last climb of euphoria before investors start to take profits.</p>\n<p><b>Final Thoughts</b></p>\n<p>Both the algorithm-adjusted fair value and the Monte Carlo simulation suggest and support the bullish rating. The results found suggest that the stock is currently undervalued and that the company has still more room to go. What may drive the price to go higher? Well, there are different factors that may drive it. One of those is for sure corporate news. For instance, the company may introduce new products or announce a stock split (For the latter, I think this is unlikely, at least not now). However, don't forget also the other side, the risks. There are many risks associated with being invested in the company, one of those is represented by antitrust and regulators.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon: Undervalued With Potential Upside Of 25%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon: Undervalued With Potential Upside Of 25%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 18:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4437291-amazon-stock-amzn-undervalued-with-potential-upside-of-25-percent><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAmazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters.\nI initiate Amazon with a bullish rating and a fair value of $3576/share (vs. ...</p>\n\n<a href=\"https://seekingalpha.com/article/4437291-amazon-stock-amzn-undervalued-with-potential-upside-of-25-percent\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://seekingalpha.com/article/4437291-amazon-stock-amzn-undervalued-with-potential-upside-of-25-percent","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113357649","content_text":"Summary\n\nAmazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters.\nI initiate Amazon with a bullish rating and a fair value of $3576/share (vs. the current price of $3443/share).\nThe company's improving top line and bottom line performance (which is expected to continue) suggests that the stock is currently undervalued by 3.9%.\n\nDaria Nipot/iStock Editorial via Getty Images\nCompany Overview\nAmazon(NASDAQ:AMZN), a $1.74 trillion company. This is the current market capitalization (as of 06/29/2021) of the company and this implies that it is currently 15.18% away from being a $2 trillion company, not bad no?\nAmazon is a unique and growing company that uses its disruptive platform to disrupt any new business it enters. For example, when Amazon announced the acquisition of Whole Foods, Walmart(NYSE:WMT), Kroger(NYSE:KR), Target(NYSE:TGT)took a nice hit in market value. I believe that the company will be able to keep delivering strong top line growth and continued growth in margins, fueled not only by the company's current business expansion but also by entering into new markets and new businesses.\nCompany Analysis\nI initiate Amazon with a bullish rating and a fair value of $3576/share (vs. the current price of $3443/share). The FV is an algorithm-adjusted fair value (the algorithm takes into account fundamental and technical factors, such as DCF FV, momentum, etc.) and it implies that the stock is undervalued by 3.9%.\nTo compute the DCF FV, I used the trailing twelve-month numbers and I also restated the financials since I capitalized on R&D expenses with an amortizable life of 3 years. As with Apple(NASDAQ:AAPL), I don't believe that Amazon's R&D is an operating expense, and for this reason, I treat it as CapEx. By taking into account the R&D, the following metrics have been restated (all numbers in $mm).\nSource:Author's estimates using data from the latest 10-K report\nCapitalizing on R&D expenses, we have now a more clear picture of the company (i.e. the restated operating margin is now 9.03% TTM vs the non-restated operating margin is 6.63% TTM).\nDiscounted Cash Flow Model\nNow, let's turn to the discounted cash flow valuation part. Below, you can see the results with the relative assumptions I have made.\nSource:Author's estimates using data from the latest 10-K report\nIn my DCF model, I assume a revenue growth for the Y1 of 21.2%, a CAGR Y2-Y5 of 15% and I assume a terminal year growth rate of 1.48% (or the current yield on 10Y Treasury). The decision of using the current and not expected yield is due to the willingness to remain market neutral (perhaps you can use Goldman Sachs expectations of 1.9%). The current assumptions lead to revenues of $1,253,844 million in Y10.\nAlong the road, I also assume an improving outlook for operating margins with the target operating margin of 13.2% (vs current restated operating margin of 9.03%). If the company will be able to meet this target, it will result in operating margins in Y10 of $163,097 million.\nFinally, in doing my estimates, I used a WACC of 5.75% and a sales to capital ratio (or how much the company is going to reinvest to keep its business growing) of 2.95.\nBy putting it together, I obtain a DCF value of $3328/share.\nMonte Carlo Simulation\nRather than showing you only my point estimates, which may be right but also may be wrong, let's use probability distributions for inputs. Simulations allow us to assess the impact of continuous risk (e.g., changes in operating margins). In particular, I would like to focus on what I consider the main inputs of interest to get a bigger picture of the risk in the company. Those inputs are:\n1. Revenue Growth:\nIn my DCF analysis, I assumed an expected CAGR Y2-Y5 of 15% with lower rates going forward. This assumption lead to revenues in Y10 of $1,253,844 million. While it is a reasonable assumption, Amazon is full of surprises, and it may deliver a top line growth well above my expectations. In the latter, I see a possible scenario with a CAGR Y2-Y5 of 24%, resulting in Y10 revenues of $1,989,952 million. However, we all know that regulators represent a big risk for the company. According to WSJ sources, if the \"giant-tech bill\" will pass, the company may be forced to either split into two companies or spin off its private-label product businesses. This represents a big risk that may slow down Amazon's growth, which could translate into a growth rate of 6% (resulting in Y10 revenues of $764,723 million). To sum up, I will assume a uniform distribution with a maximum of 24% and a minimum of 6%. The results are displayed below (this simulation and the next one have been performed 10,000 times).\nSource:Author's estimates\n2. Operating Margin:\nCurrently, Amazon has a restated operating margin of 9.03% TTM (vs not restated EBIT margin of 6.83%). In my DCF, I assumed a target operating margin of 13.2%. While this represents my most likely scenario for the company, I cannot close my eyes to the fact that, even if the company is improving its margins, it is following a very slow climb. Below, I display the non-restated EBIT margin for the last 5 years.\nSource:SeekingAlpha.com\nHowever, as I stated at the beginning, Amazon is a disruptive company with the ability to do extraordinary things. For instance, AWS presents a current operating margin of 30% TTM and a revenue growth rate of 29.53% in 2020. A trend which is expected to continue, driven by improving outlook and with new partners joining the party. The last to join the party are Ferrari(NYSE:RACE)and Swisscom(OTCPK:SWZCF)who have chosen AWS as their preferred cloud partner.\nIn 2020,according to Gartner, AWS generated revenue 2 times bigger than Microsoft(NASDAQ:MSFT). As stated by Gartner:\n\nThe worldwide \n infrastructure as a service(IaaS) market grew 40.7% in 2020 to total $64.3 billion, up from $45.7 billion in 2019, according to Gartner, Inc. Amazon retained the No. 1 position in the IaaS market in 2020, followed by Microsoft, Alibaba, Google and Huawei... Amazon continued to lead the worldwide IaaS market with $26.2 billion of revenue in 2020 and 41% market share.\n\nSource:Gartner.com\nFinally, to account for my concerns and beliefs, I will assume a triangular distribution with the following limits: the likeliest target operating margin of 13.2%, a maximum of 18.4%, and a minimum of 8% (close to the current company's EBIT margin). The results are displayed below.\nSource:Author's estimates\n3. Cost of Capital:\nThe last input of interest is the cost of capital. In doing my analysis, I estimated a cost of capital of 5.8% (with the current 10Y rate of 1.48 and an implied ERP of 4.54%). However, I may be wrong due to sector risk estimates or changes in the business mix (or both). To account for the possibility that I made some mistakes along the road, I will rely on a lognormal distribution with the most likely scenario of 5.8%. The results of the simulation are displayed below.\nSource:Author's estimates\nBy putting all of this together, the simulations return the following results.\nSource:Author's estimates\nFor completeness, I also display below the relative and cumulative frequency of the simulation.\nSource:Author's estimates\nBy looking at the results, we can see that the 50th percentile or the median is equal to $3274, close to the expected DCF FV of $3328. While the algorithm-adjusted FV of $3576 is the 60th percentile in my simulations (note also the long right tail).\nFinally, simulation results give us an interesting insight into a potential exit point. I believe that an interesting take profit point may be within the 80th percentile, which implies a potential upside of 24.89%. Why within the 80th percentile? I believe that, after reaching the $2.0 trillion company status, we will see the last climb of euphoria before investors start to take profits.\nFinal Thoughts\nBoth the algorithm-adjusted fair value and the Monte Carlo simulation suggest and support the bullish rating. The results found suggest that the stock is currently undervalued and that the company has still more room to go. What may drive the price to go higher? Well, there are different factors that may drive it. One of those is for sure corporate news. For instance, the company may introduce new products or announce a stock split (For the latter, I think this is unlikely, at least not now). However, don't forget also the other side, the risks. There are many risks associated with being invested in the company, one of those is represented by antitrust and regulators.","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122750070,"gmtCreate":1624634257590,"gmtModify":1631893538751,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Wowww&nbsp;","listText":"Wowww&nbsp;","text":"Wowww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/122750070","repostId":"2146023165","repostType":4,"isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129680825,"gmtCreate":1624370883267,"gmtModify":1634007125185,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Thankss","listText":"Thankss","text":"Thankss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129680825","repostId":"2145056554","repostType":4,"repost":{"id":"2145056554","kind":"highlight","pubTimestamp":1624356900,"share":"https://ttm.financial/m/news/2145056554?lang=&edition=full","pubTime":"2021-06-22 18:15","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2145056554","media":"Motley Fool","summary":"Here are the companies investors are most excited about -- and why.","content":"<p>The <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.</p>\n<p>Yet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.</p>\n<h3>UnitedHealth: 34% upside</h3>\n<p><b>UnitedHealth Group </b>(NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.</p>\n<p>Yet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.</p>\n<p>UnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.</p>\n<p>Indeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.</p>\n<p><img src=\"https://static.tigerbbs.com/ffe66b7aafd67e07dd42007f2b60d638\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>Yet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.</p>\n<h3>Goldman Sachs: 36% upside</h3>\n<p>Wall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank <b>Goldman Sachs </b>(NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.</p>\n<p>On <a href=\"https://laohu8.com/S/AONE\">one</a> hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.</p>\n<p>On the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&amp;A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&amp;A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.</p>\n<h3>Apple: 42% upside</h3>\n<p>Lastly, <b>Apple </b>(NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.</p>\n<p>Apple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.</p>\n<p>Many fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.</p>\n<h3>Further to run?</h3>\n<p>Even with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 18:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛","AAPL":"苹果","09086":"华夏纳指-U","03086":"华夏纳指","UNH":"联合健康"},"source_url":"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145056554","content_text":"The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.\nYet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.\nUnitedHealth: 34% upside\nUnitedHealth Group (NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.\nYet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.\nUnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.\nIndeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.\n\nImage source: Getty Images.\nYet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.\nGoldman Sachs: 36% upside\nWall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank Goldman Sachs (NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.\nOn one hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.\nOn the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.\nApple: 42% upside\nLastly, Apple (NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.\nApple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.\nMany fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.\nFurther to run?\nEven with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.","news_type":1,"symbols_score_info":{"03086":0.9,"09086":0.9,"AAPL":0.9,"GS":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":844027106,"gmtCreate":1636379246232,"gmtModify":1636379278835,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844027106","repostId":"1114414245","repostType":4,"isVote":1,"tweetType":1,"viewCount":1225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862927814,"gmtCreate":1632832329644,"gmtModify":1632832329750,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"themes":[],"htmlText":"Hohoho&nbsp;","listText":"Hohoho&nbsp;","text":"Hohoho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862927814","repostId":"1126986798","repostType":4,"repost":{"id":"1126986798","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632827257,"share":"https://ttm.financial/m/news/1126986798?lang=&edition=full","pubTime":"2021-09-28 19:07","market":"us","language":"en","title":"Sonoma Pharmaceuticals shares surged 45% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1126986798","media":"Tiger Newspress","summary":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou","content":"<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals shares surged 45% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals shares surged 45% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 19:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p>\n<p><img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p>\n<p>Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p>\n<p>Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p>\n<p>Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p>\n<p>MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p>\n<p><b>About Sonoma Pharmaceuticals, Inc.</b></p>\n<p>Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOA":"Sonoma Pharmaceuticals, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126986798","content_text":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.\n\nSonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.\nSonoma offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.\nRegenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.\nOcucyn Eyelid & Eyelash Cleanser, designed for everyday use, is a safe, gentle & effective solution for good eyelid & eyelash hygiene. Ocucyn Eyelid & Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid & Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.\nMucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.\nAbout Sonoma Pharmaceuticals, Inc.\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.","news_type":1,"symbols_score_info":{"SNOA":0.9}},"isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}